Publications and communications of Brigitte Evrard

Koch, N., Jennotte, O., Bourcy, Q., Lechanteur, A., DEVILLE, M., Charlier, C., CHIAP, P., Cardot, J. M., & Evrard, B. (27 April 2024). Evaluation of amorphous and lipid-based formulation strategies to increase the in vivo cannabidiol bioavailability in piglets. International Journal of Pharmaceutics, 657, 124173. doi:10.1016/j.ijpharm.2024.124173

Ayyoubi, S., Jennotte, O., Lechanteur, A., Evrard, B., & Ruigjrok, L. (21 April 2024). Will 3D printing replace manual compounding? [Poster presentation]. PBP World meeting, Vienne, Austria.

Bya, L.-A., Coeurderoi, A., Dinh, T. N., Bottero, B., Sacre, P.-Y., Ziemons, E., Cataldo, D., Piel, G., Lechanteur, A., & Evrard, B. (17 April 2024). Assessment of the Effects of Drying Methods on Powder Properties: A Comparative Study of Spray Drying from Solution and Suspension [Poster presentation]. 9th Workshop on Pulmonary Drug Delivery, Dublin, Ireland.

Degey, M., Berger, M., Evrard, B., & Piel, G. (10 April 2024). Exploring alternatives to PEG for the formulation of lipid nanoparticles encapsulating siRNA [Poster presentation]. 17th European Symposium on Controlled Drug Delivery.

Gauthy, C., Gihozo Uwera, A., Evrard, B., Malgrange, B., & Piel, G. (10 April 2024). Effect of the composition of liposomes on dexamethasone encapsulation and its kinetics of release [Poster presentation]. ESCDD Symposium 2024, Egmond aan Zee, Netherlands.

Gauthy, C., Evrard, B., Malgrange, B., & Piel, G. (19 March 2024). Optimization of liposomal formulation to achieve sustained release of dexamethasone [Poster presentation]. 14th PBP World Meeting, Vienne, Austria.

Gresse, E., Rousseau, J., Akdim, M., Du Bois, A., Lechanteur, A., & Evrard, B. (2024). Enhancement of inhaled micronized powder flow properties for accurate capsules filling. Powder Technology, (119576). doi:10.1016/j.powtec.2024.119576

Penoy, N.* , Delma, K. L.* , Homkar, N., Karim Sakira, A., Egrek, S., Sacheli, R., Sacre, P.-Y., Grignard, B., Hayette, M.-P., Somé, T. I., Semdé, R., Evrard, B., & Piel, G. (15 February 2024). Development and optimization of a one step process for the production and sterilization of liposomes using supercritical CO2. International Journal of Pharmaceutics, 651, 123769. doi:10.1016/j.ijpharm.2024.123769
* These authors have contributed equally to this work.

Bya, L.-A., Coeurderoi, A., Dinh, T. N., Piel, G., Lechanteur, A., & Evrard, B. (31 January 2024). STUDY OF THE IMPACT OF DRYING PROCESSES ON POWDER PROPERTIES: A COMPARATIVE ANALYSIS OF SPRAY-DRYING TECHNOLOGY FROM SOLUTION AND SUSPENSION [Paper presentation]. CIRM day 2024 - Scientific Day, Liège, Belgium.

Degey, M., Berger, M., Evrard, B., & Piel, G. (31 January 2024). New amphiphilic polymers with variable length and number of lipid chains as alternatives to PEG for the formulation of lipid nanoparticles encapsulating siRNA [Poster presentation]. CIRM DAY - Scientific day, Liege, Belgium.

Gauthy, C., Gihozo Uwera, A., Evrard, B., Malgrange, B., & Piel, G. (31 January 2024). Optimization of liposomal composition to efficiently encapsulate dexamethasone or dexamethasone phosphate and enable their sustained release [Poster presentation]. CIRM Day, Liège, Belgium.

Koch, N., Jennotte, O., Lechanteur, A., Grignard, B., & Evrard, B. (17 January 2024). Improvement of aqueous solubility of active pharmaceutical ingredients by using mesoporous silica impregnation under pressurized carbon dioxide [Paper presentation]. 1st FRITCO2T Day.

Koch, N., Jennotte, O., Lechanteur, A., DEVILLE, M., Charlier, C., Cardot Jean-Michel, CHIAP, P., & Evrard, B. (2024). An Intravenous Pharmacokinetic Study of Cannabidiol Solutions in Piglets through the Application of a Validated Ultra-High-Pressure Liquid Chromatography Coupled to Tandem Mass Spectrometry Method for the Simultaneous Quantification of CBD and Its Carboxylated Metabolite in Plasma. Pharmaceutics. doi:10.3390/pharmaceutics16010140

Penoy, N., Delma, K. L.* , Berger, M., Evrard, B., & Piel, G. (2024). Supercritical fluid methods for liposome production and sterilization. In Antimisiaris Sophia G., Liposomes in drug delivery : what, where, how and when to deliver. Elsevier.
* These authors have contributed equally to this work.

Gaspar, A., Philippe, G., Evrard, B., Herné, P., Manfredini, T., & Delguste, C. (21 December 2023). VET&PHARM pilot project: A case study focusing on the perceived value of a pilot seminar on interprofessional communication for students in Pharmacy and Veterinary Medicine in the rational delivery of drugs for veterinary use [Poster presentation]. 10th FarahDay of the Faculuty of Veterinary Medicine, Liège, Belgium.

Berger, M.* , Toussaint, F.* , Djemaa, S. B.* , Maquoi, E., Pendeville-Samain, H., Evrard, B., Jérôme, C., Chain, J. L., Lechanteur, A., Mottet, D.* , Debuigne, A.* , & Piel, G.*. (2023). Poly(N-methyl‐N‐vinylacetamide): a strong alternative to PEG for lipid‐based nanocarriers delivering siRNA. Advanced Healthcare Materials, 2302712. doi:10.1002/adhm.202302712
* These authors have contributed equally to this work.

Jennotte, O., Koch, N., Lechanteur, A., & Evrard, B. (September 2023). Formulation and quality consideration of cannabidiol printed forms produced by fused-deposition modeling. Journal of Drug Delivery Science and Technology, 87, 104837. doi:10.1016/j.jddst.2023.104837

Lechanteur, A., Gresse, E., Orozco, L., Plougonven, E., Léonard, A., Vandewalle, N., Lumay, G., & Evrard, B. (16 August 2023). Inhalation powder development without carrier: how to engineer ultra-flying microparticles? European Journal of Pharmaceutics and Biopharmaceutics, 191, 26 - 35. doi:10.1016/j.ejpb.2023.08.010

Berger, M.* , Toussaint, F.* , Djemaa, S. B.* , Laloy, J., Pendeville-Samain, H., Evrard, B., Jérôme, C., Lechanteur, A., Mottet, D.* , Debuigne, A.* , & Piel, G.*. (02 August 2023). Poly(vinyl pyrrolidone) derivatives as PEG alternatives for stealth, non-toxic and less immunogenic siRNA-containing lipoplex delivery. Journal of Controlled Release, 361, 87 - 101. doi:10.1016/j.jconrel.2023.07.031
* These authors have contributed equally to this work.

Parulski, C., Bya, L.-A., Goebel, J., Servais, A.-C., Lechanteur, A., & Evrard, B. (13 June 2023). Development of 3D printed mini-waffle shapes containing hydrocortisone for children's personalized medicine. International Journal of Pharmaceutics, 642 (123131). doi:10.1016/j.ijpharm.2023.123131

Penoy, N., Delma, K. L., Grignard, B., Evrard, B., & Piel, G. (23 May 2023). The use of supercritical CO2 to develop liposomes encapsulating active pharmaceutical ingredients for pulmonary administration [Poster presentation]. 19th European Meeting on Supercritical Fluids, Budapest, Hungary.

Dinh, T. N., Bya, L.-A., Lechanteur, A., Penoy, N., Evrard, B., & Piel, G. (28 April 2023). LIPOSOME FOR THE TREATMENT OF COPD PRODUCED BY SUPERCRITICAL CARBON DIOXIDE-BASED TECHNOLOGIES [Paper presentation]. 21st Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Gauthy, C., Penoy, N., Evrard, B., Malgrange, B., & Piel, G. (28 April 2023). Development of optimized liposomes for sustained-release transtympanic administration [Paper presentation]. 21st Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (27 April 2023). Effect of PEG anchor and serum on Lipid Nanoparticles: development of a nanoparticle tracking method [Paper presentation]. 21st Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Gresse, E., Rousseau, J., du Bois, A., Lechanteur, A., & Evrard, B. (27 April 2023). HOW TO IMPROVE ENGINEERED MICRONIZED POWDER FLOWABILITY? [Paper presentation]. 21st Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Parulski, C., Bya, L.-A., Goebel, J., Servais, A.-C., Lechanteur, A., & Evrard, B. (27 April 2023). The future of 3D printing for personalized medicine: Could 3D printed waffle shapes replace the magistral preparation of hydrocortisone capsules? [Paper presentation]. 21st Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Penoy, N., Delma, K. L., EGREK, S., Grignard, B., Sacheli, R., Sacre, P.-Y., Hayette, M.-P., Evrard, B., & Piel, G. (27 April 2023). Supercritical CO2 to produce and sterilize liposomes: How to find supercritical parameters with the QbD strategy [Paper presentation]. BSPS - 21th Forum of Pharmaceutical Sciences, Blankerberge, Belgium.

Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (21 March 2023). Impact of the hydrophobic chain length of PEG derivatives on the behavior of LNPs in serum: Development of a Nanoparticle Tracking Analysis (NTA) Method [Poster presentation]. 4th European Conference on Pharmaceutics, Marseille, France.

Gresse, E., du Bois, A., Rousseau, J., Lechanteur, A., & Evrard, B. (20 March 2023). How to improve engineered micronized powder flowability? [Poster presentation]. 4th European Conference on Pharmaceutics, Marseille, France.

Jennotte, O., Lechanteur, A., Koch, N., Evrard, B., Rosoux François, Emmerechts Carl, & Beeckman Eric. (20 March 2023). Formulation and Quality Consideration of Printed Tablets of Cannabidiol Produced by Direct Powder Extrusion [Poster presentation]. 4th European Conference on Pharmaceutics, Marseille, France.

Parulski, C., Goebel, J., Bya, L.-A., Lechanteur, A., & Evrard, B. (20 March 2023). Could 3D printed waffle shapes replace the magistral preparation of hydrocortisone capsules for children’s personalized medicine? [Poster presentation]. 4th European Conference on Pharmaceutics, Marseille, France.

Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (10 February 2023). Effect of PEG Anchor and Serum on Lipid Nanoparticles: Development of a Nanoparticles Tracking Method. Pharmaceutics, 15 (2). doi:10.3390/pharmaceutics15020597

Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (01 February 2023). Effect of PEG anchor and serum on Lipid Nanoparticles: development of a nanoparticles tracking method [Paper presentation]. CIRM Day, Liege, Belgium.

Dinh, T. N., Bya, L.-A., Lechanteur, A., Penoy, N., Evrard, B., & Piel, G. (01 February 2023). Liposome containing ciclesonide with/without indacaterol produced by supercritical carbon dioxide-based technologies [Poster presentation]. CIRM Day, Liège, Belgium.

Dinh, T. N., Bya, L.-A., Lechanteur, A., Penoy, N., Evrard, B., & Piel, G. (01 February 2023). Liposome containing ciclesonide with/without indacaterol produced by supercritical carbon dioxide-based technologies [Poster presentation]. CIRM Day, Liège, Belgium.

Gauthy, C., Penoy, N., Evrard, B., Malgrange, B., & Piel, G. (01 February 2023). Development of a sustained-release form of dexamethasone for the local treatment of sensorineural hearing loss [Poster presentation]. CIRM Day, Liège, Belgium.

Delma, K. L., Penoy, N., Sakira, A. K., EGREK, S., Sacheli, R., Grignard, B., Hayette, M.-P., Issa Somé, T., Evrard, B., Semdé, R., & Piel, G. (11 January 2023). Use of supercritical CO2 for the sterilization of liposomes: Study of the influence of sterilization conditions on the chemical and physical stability of phospholipids and liposomes. European Journal of Pharmaceutics and Biopharmaceutics, 183, 112 - 118. doi:10.1016/j.ejpb.2023.01.002

Bya, L.-A., Dinh, T. N., Piel, G., Lechanteur, A., & Evrard, B. (2023). Inhaled dry powder containing lipid-nanoparticles: particle engineering by spray-drying technology [Paper presentation]. 21st Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Dinh, T. N., Bya, L.-A., Lechanteur, A., Penoy, N., Evrard, B., & Piel, G. (2023). LIPOSOME FOR THE TREATMENT OF COPD PRODUCED BY SUPERCRITICAL CARBON DIOXIDE-BASED TECHNOLOGIES [Paper presentation]. 21st Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Koch, N., Jennotte, O., Bourcy, Q., Lechanteur, A., Chiap, P., & Evrard, B. (2023). How the choice of dissolution parameters influences the interpretation of dissolution efficiency from two different cannabidiol formulations? [Poster presentation]. 4th European Conference on Pharmaceutics, Marseille, France.

Koch, N., Jennotte, O., Bourcy, Q., Lechanteur, A., & Evrard, B. (2023). How the choice of dissolution parameters influences the interpretation of dissolution efficiency from two different cannabidiol formulations? [Paper presentation]. CIRM day 2023.

Koch, N., Jennotte, O., Toussaint, C., Lechanteur, A., & Evrard, B. (2023). Production challenges of tablets containing lipid excipients: case study using cannabidiol as drug model. International Journal of Pharmaceutics, 122639. doi:10.1016/j.ijpharm.2023.122639

Nyamba, I., Jennotte, O., Charles B Sombié, Lechanteur, A., Sacre, P.-Y., Abdoulaye Djandé, Rasmane Semde, & Evrard, B. (2023). Preformulation study for the selection of a suitable polymer for the development of ellagic acid-based solid dispersion using hot-melt extrusion. International Journal of Pharmaceutics. doi:10.1016/j.ijpharm.2023.123088

Parulski, C., Goebel, J., Bya, L.-A., Servais, A.-C., Lechanteur, A., & Evrard, B. (2023). Could 3D printed waffle shapes replace hydrocortisone capsules prepared in community pharmacies for children’s personalized medicine? [Paper presentation]. Center for Interdisciplinary Research on Medicines (CIRM) Scientific Day, Liège, Belgium.

Ayyoubi, S., Van Kampen, E., Kocabas, L. I., Parulski, C., Lechanteur, A., Evrard, B., De Jager, K., Muller, E., Wilms, E. W., Meulenhoff, P. W. C., & Ruijgrok, E. J. (December 2022). 3D printed, personalized sustained release cortisol for patients with adrenal insufficiency. International Journal of Pharmaceutics, 630, 122466. doi:10.1016/j.ijpharm.2022.122466

Penoy, N., Delma, K. L., Tonakpon, H. A., Grignard, B., Evrard, B., & Piel, G. (October 2022). An innovative one step green supercritical CO2 process for the production of liposomes co-encapsulating both a hydrophobic and a hydrophilic compound for pulmonary administration. International Journal of Pharmaceutics, 627, 122212. doi:10.1016/j.ijpharm.2022.122212

Gresse, E., du Bois, A., Lechanteur, A., & Evrard, B. (30 September 2022). How to improve engineered micronized powder flowability? [Paper presentation]. GALENUS WORKSHOP ON RECENT DEVELOPMENTS IN PARTICLE ENGINEERING, Graz, Austria.

Parulski, C., Gresse, E., Jennotte, O., Felten, A., Ziemons, E., Lechanteur, A., & Evrard, B. (31 August 2022). Fused deposition modeling 3D printing of solid oral dosage forms containing amorphous solid dispersions: How to elucidate drug dissolution mechanisms through surface spectral analysis techniques? International Journal of Pharmaceutics, 626, 122157. doi:10.1016/j.ijpharm.2022.122157

Jennotte, O., Koch, N., Lechanteur, A., & Evrard, B. (2022). Development of amorphous solid dispersions of cannabidiol: Influence of the carrier, the hot-melt extrusion parameters and the use of a crystallization inhibitor. Journal of Drug Delivery Science and Technology, 103372. doi:10.1016/j.jddst.2022.103372

Berger, M., Toussaint, F., Ben Djemaa, S., Evrard, B., Jérôme, C., Lechanteur, A., Mottet, D., Debuigne, A., & Piel, G. (30 March 2022). Development of innovative grafted lipoplexes using PNVP-derivatives polymers as a PEG alternative to treat cancer [Paper presentation]. 13th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (PBP World Meeting), Rotterdam, Netherlands.

Jennotte, O., Koch, N., Rosoux, F., Emmerechts Carl, Beeckman Eric, Lechanteur, A., & Evrard, B. (30 March 2022). Formulation and Quality Consideration of Cannabidiol Printlets Produced by Fused-Deposition Modeling [Poster presentation]. 13th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology.

Parulski, C., Gresse, E., Jennotte, O., Lechanteur, A., & Evrard, B. (30 March 2022). How do polymer composition and infill density of 3D printed oral forms influence the dissolution rate of a BCSII molecule ? [Poster presentation]. 13th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (PBP), Rotterdam, Netherlands.

Delma, K. L., Delma, K. L., Penoy, N., Grignard, B., Semdé, R., Evrard, B., & Piel, G. (29 March 2022). Effects of supercritical carbon dioxide under conditions potentially conducive to sterilization on chemical stability of phospholipids and physicochemical characteristics of a liposome formulation [Poster presentation]. 13th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Rotterdam, Netherlands.

Nyamba, I., Jennotte, O., Charles B Sombié, Lechanteur, A., Rasmané Semdé, & Evrard, B. (27 March 2022). Polymer screening for the development of solid dispersion formulations based on ellagic acid by Hot melt extrusion [Poster presentation]. world meeting on pharmaceutics, biopharmaceutics and pharmaceutical technology, Rotterdam, Netherlands.

Lechanteur, A., Plougonven, E., Orozco Ardila, L., Gresse, E., Lumay, G., Vandewalle, N., Léonard, A., & Evrard, B. (25 March 2022). Engineered-inhaled particles: influence of carbohydrates excipients nature on powder properties and behavior [Poster presentation]. PBP world meeting 2022.

Parulski, C., Gresse, E., Jennotte, O., Lechanteur, A., & Evrard, B. (10 March 2022). How do infill density and polymer composition of 3D printed solid oral forms impact the dissolution profile of a BSCII drug ? [Paper presentation]. CRS Local Chapters meeting Aachen, Aachen, Germany.

Berger, M., Toussaint, F., Ben Djemaa, S., Evrard, B., Jérôme, C., Lechanteur, A., Mottet, D., Debuigne, A., & Piel, G. (09 March 2022). Development of innovative grafted lipoplexes using PNVP-derivatives polymers as a PEG alternative to treat cancer [Paper presentation]. 2022 Meeting of the Germany and BeNeLux & France Local Chapters of the Controlled Release Society in Aachen, Aachen, Germany.

Koch, N., Jennotte, O., Lechanteur, A., & Evrard, B. (March 2022). Cannabidiol tablets with an enhanced bioavailability: Optimal selection of excipients and tableting through Design of Experiments [Poster presentation]. PBP 13th World Meeting, Rotterdam, Netherlands.

Berger, M., Toussaint, F., Evrard, B., Jérôme, C., Lechanteur, A., Debuigne, A., & Piel, G. (02 February 2022). PNVP-polymers as a promising polyethyleneglycol (PEG) alternative onto anti-tumor lipoplexes surface [Paper presentation]. CIRM-Day, Liege, Belgium.

Delma, K. L., Delma, K. L., Penoy, N., Grignard, B., Semdé, R., Evrard, B., & Piel, G. (02 February 2022). Applicability of supercritical carbon dioxide sterilization to liposomes: effects of potential conditions on phospholipids and liposomes stability [Paper presentation]. CIRM day 2022, Liège, Belgium.

Jennotte, O., Koch, N., Lechanteur, A., & Evrard, B. (02 February 2022). Formulation and Quality Consideration of Cannabidiol Printlets Produced by Fused-Deposition Modeling [Paper presentation]. CIRM DAY 2022.

Koch, N., Jennotte, O., Lechanteur, A., & Evrard, B. (02 February 2022). Development of cannabidiol lipid-dispersion tablets: excipients selection and tabletability [Paper presentation]. CIRM Day 2022.

Nyamba, I., Sombié, C., Lechanteur, A., Semdé, R., & Evrard, B. (02 February 2022). Complexation with cyclodextrins and solid dispersions formation as physical formulation approaches for improving aqueous solubility and bioavailability of ellagic acid [Paper presentation]. CIRM Day 2022, Liège, Belgium.

Parulski, C., Gresse, E., Jennotte, O., Lechanteur, A., & Evrard, B. (02 February 2022). Developement of stable amorphous solid dispersions by hot-melt extrusion coupled with 3D printing to enhance the dissolution rate of a BCSII active molecule: Impact of infill density and polymer composition [Paper presentation]. Center for Interdisciplinary Research on Medicines (CIRM) Scientific Day, Liège, Belgium.

Delma, K. L., Penoy, N., Grignard, B., Semdé, R., Evrard, B., & Piel, G. (January 2022). Effects of supercritical carbon dioxide under conditions potentially conducive to sterilization on physicochemical characteristics of a liposome formulation containing apigenin. Journal of Supercritical Fluids, 179, 105418. doi:10.1016/j.supflu.2021.105418

Koch, N., Jennotte, O., Ziemons, E., Boussard, G., Lechanteur, A., & Evrard, B. (2022). Influence of API physico-chemical properties on amorphization capacity of several mesoporous silica loading methods. International Journal of Pharmaceutics. doi:10.1016/j.ijpharm.2021.121372

Lechanteur, A., Plougonven, E., Orozco, L., Lumay, G., Vandewalle, N., Léonard, A., & Evrard, B. (2022). Engineered-inhaled particles: Influence of carbohydrates excipients nature on powder properties and behavior. International Journal of Pharmaceutics, 121319. doi:10.1016/j.ijpharm.2021.121319

Delma, K. L., Evrard, B., Piel, G., Semdé, R., & Sakira, A. K. (04 November 2021). Etude de l’applicabilité de la stérilisation par le dioxyde de carbone supercritique aux liposomes : effets de conditions opératoires sur la stabilité chimique de phospholipides [Paper presentation]. 2ème Congrès de la Société Ouest Africaine de Pharmacie Galénique et Industrielle (SOAPGI), Ouagadougou, Burkina Faso.

Nyamba, I., Charle SOMBIE, Lechanteur, A., Rasmané Semdé, & Evrard, B. (03 November 2021). Augmentation de la solubilité et de la biodisponibilité de l’acide ellagique par complexation à l’aide de cyclodextrines en vue de son utilisation comme antipaludique: formulation et caractérisation par spectroscopie infrarouge à transformée de Fourier [Paper presentation]. Congrès, Ouagadougou, Burkina Faso.

Dori, D., Ouedraogo, H. W. B., Houngue, P. D., Gbaguidi, F. A., Evrard, B., Quetin-Leclercq, J., & Semdé, R. (October 2021). Study of Manufacturing Conditions of Medicines Derived from Traditional Pharmacopoeia in Benin and Burkina Faso. Phytothérapie, 19 (5-6), 372-378. doi:10.3166/phyto-2021-0295

Parulski, C., Jennotte, O., Lechanteur, A., & Evrard, B. (August 2021). Challenges of fused deposition modeling 3D printing in pharmaceutical applications: Where are we now? Advanced Drug Delivery Reviews, 175. doi:10.1016/j.addr.2021.05.020

Berger, M., Lechanteur, A., Evrard, B., & Piel, G. (2021). Innovative lipoplexes formulations with enhanced siRNA efficacy for cancer treatment: Where are we now? International Journal of Pharmaceutics. doi:10.1016/j.ijpharm.2021.120851

Parulski, C., Gresse, E., Jennotte, O., Lechanteur, A., & Evrard, B. (26 May 2021). How do polymer composition and infill density of 3D printed tablets influence the dissolution rate of itraconazole ? [Paper presentation]. Center for Interdisciplinary Research on Medicines (CIRM) Scientific Day, Liège, Belgium.

Koch, N., Jennotte, O., Lechanteur, A., & Evrard, B. (14 May 2021). Improvement of fenofibrate aqueous solubility by using mesoporous silica impregnation under pressurized carbon dioxide [Poster presentation]. PBP 12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology.

Berger, M., Toussaint, F., Ben Djemaa, S., Evrard, B., Jérôme, C., Debuigne, A., Mottet, D., Lechanteur, A., & Piel, G. (May 2021). Impact of amphiphilic N-vinyl pyrrolidone-based polymers used as PEG alternative on lipoplexes physico-chemical properties, cytotoxicity and gene delivery [Poster presentation]. Center for Interdisciplinary Research on Medicines (CIRM) Scientific Day, Liège, Belgium.

Berger, M., Toussaint, F., Pairoux, C., Evrard, B., Jérôme, C., Lechanteur, A., Debuigne, A., & Piel, G. (06 April 2021). Amphiphilic N-vinyl pyrrolidone-based polymers as PEG alternatives to avoid blood proteins adsorption around liposomes [Paper presentation]. Early Career Scientist Meeting 2021.

Jennotte, O., Koch, N., Lechanteur, A., & Evrard, B. (06 April 2021). Amorphous solid dispersions of cannabidiol with an increase of the aqueous solubility: influence of the carrier, the hot melt extrusion parameters and the use of a crystallization inhibitor [Paper presentation]. The Controlled Release Society BeNeLux&France Early Career Scientists Meeting 2021.

Koch, N., Jennotte, O., Lechanteur, A., & Evrard, B. (06 April 2021). Influence of API physico-chemical properties on amorphization capacity of several mesoporous silica loading methods [Paper presentation]. CRS BNFL ECS Meeting 2021.

Parulski, C., Gresse, E., Jennotte, O., Lechanteur, A., & Evrard, B. (06 April 2021). How do infill density and polymer composition of tablets produced by hotmelt extrusion coupled with Fused Deposition Modeling 3D printing influence the dissolution profile of a BCS II molecule ? [Paper presentation]. CRS Local Chapter Meeting.

Penoy, N., Grignard, B., Evrard, B., & Piel, G. (06 April 2021). Double Encapsulation in liposomes for pulmonary administration produced by an innovative supercritical process [Paper presentation]. Controlled Release Society BeNeLux&France Early Career Scientists Meeting (online).

Berger, M., Toussaint, F., Pairoux, C., Evrard, B., Jérôme, C., Lechanteur, A., Debuigne, A., & Piel, G. (04 March 2021). Impact of amphiphilic copolymer used as PEG alternative on the formation of a protein corona around coated-liposomes encapsulating siRNA [Paper presentation]. 2021 - Virtual Local Chapter Meeting Germany and BeNeLux & France, Aachen, Germany.

Parulski, C., Gresse, E., Jennotte, O., Lechanteur, A., & Evrard, B. (04 March 2021). Investigation of the impact of polymer composition and infill density of solid oral forms produced by hot-melt extrusion coupled with 3D printing on the dissolution rate of itraconazole [Paper presentation]. CRS Local Chapter Meeting, Aachen, Germany.

Penoy, N., Grignard, B., Evrard, B., & Piel, G. (04 March 2021). A supercritical PGSS method to encapsulate budesonide in liposome: comparison with the classical tFH method [Paper presentation]. CRS Local Chapters Meeting Germany and BeNeLux & France (online).

Penoy, N., Koch, N., Grignard, B., Evrard, B., & Piel, G. (March 2021). The quality by design strategy to prepare different liposomes formulations by a new supercritical fluid method [Poster presentation]. APGI Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology.

Sounouvou, A. G. H. T., Defourny, C., Gbaguidi, F., Ziemons, E., Piel, G., Quetin-Leclercq, J., & Evrard, B. (01 March 2021). Development of a highly persistent silicone-based sprayable emulsion containing essential oils for treatment of skin infections. International Journal of Pharmaceutics, 596. doi:10.1016/j.ijpharm.2021.120214

Sounouvou, A. G. H. T., Toukourou, H., Catteau, L., Toukourou, F., Evrard, B., Van Bambeke, F., Gbaguidi, F., & Quetin-Leclercq, J. (01 March 2021). Antimicrobial potentials of essential oils extracted from West African aromatic plants on common skin infections. Scientific African, 11. doi:10.1016/j.sciaf.2021.e00706

Bellefroid, C., Reusch, C., Lechanteur, A., Evrard, B., Debacq-Chainiaux, Mottet, D., & Piel, G. (2021). Systematic study of liposomes composition towards efficient delivery of plasmid DNA as potential application of dermal fibroblasts targeting. International Journal of Pharmaceutics, 592, 120122. doi:10.1016/j.ijpharm.2020.120122

Delma, K. L., Lechanteur, A., Semde, R., Evrard, B., & Piel, G. (2021). Sterilization methods of liposomes: drawbacks of conventional methods and perspectives. International Journal of Pharmaceutics. doi:10.1016/j.ijpharm.2021.120271

Penoy, N., Grignard, B., Evrard, B., & Piel, G. (2021). A supercritical fluid technology for liposome production and comparison with the film hydration method. International Journal of Pharmaceutics, 592, 120093. doi:10.1016/j.ijpharm.2020.120093

Delma, K. L., Evrard, B., Piel, G., & Semdé, R. (December 2020). Stérilisation des liposomes par le dioxyde de carbone en phase supercritique : effets des conditions sur leurs caractéristiques physicochimiques [Paper presentation]. 1er Journées Scientifiques de l’Institut de Recherche en Sciences de la Santé, Ouagadougou, Burkina Faso.

Nyamba, I., Lechanteur, A., Semdé, R., & Evrard, B. (2020). Physical formulation approaches for improving aqueous solubility and bioavailability of ellagic acid: A review. European Journal of Pharmaceutics and Biopharmaceutics. doi:10.1016/j.ejpb.2020.11.004

Koch, N., Jennotte, O., Grignard, B., Lechanteur, A., & Evrard, B. (01 July 2020). Impregnation of mesoporous silica with poor aqueous soluble molecule using pressurized carbon dioxide: is the solubility in the supercritical and subcritical phase a critical parameter? European Journal of Pharmaceutical Sciences, 150, 105332. doi:10.1016/j.ejps.2020.105332

Lechanteur, A., & Evrard, B. (2020). Influence of Composition and Spray-Drying Process Parameters on Carrier-Free DPI Properties and Behaviors in the Lung: A review. Pharmaceutics. doi:10.3390/pharmaceutics12010055

Gallez, A.* , Palazzo, C.* , Blacher, S., Tskitishvili, E., Noël, A., Foidart, J.-M., Evrard, B., Pequeux, C.* , & Piel, G.*. (05 January 2020). Liposomes and drug-in-cyclodextrin-in-liposomes formulations encapsulating 17β-estradiol: an innovative drug delivery system that prevents the activation of the membrane-initiated steroid signaling (MISS) of estrogen receptor α. International Journal of Pharmaceutics, 573, 118861. doi:10.1016/j.ijpharm.2019.118861
* These authors have contributed equally to this work.

Bayiha, J. C., Evrard, B., Cataldo, D., De Tullio, P., & Mingeot-Leclercq, M.-P. (2020). The Budesonide-Hydroxypropyl-β-Cyclodextrin Complex Attenuates ROS Generation, IL-8 Release and Cell Death Induced by Oxidant and Inflammatory Stress. Study on A549 and A-THP-1 Cells. Molecules, 25, 4882. doi:10.3390/molecules25214882

Jennotte, O., Koch, N., Lechanteur, A., & Evrard, B. (2020). Three-dimensional printing technology as a promising tool in bioavailability enhancement of poorly water-soluble molecules: a review. International Journal of Pharmaceutics. doi:10.1016/j.ijpharm.2020.119200

Koch, N., Jennotte, O., Gasparrini, Y., Vandenbroucke, F., Lechanteur, A., & Evrard, B. (2020). Cannabidiol aqueous solubility enhancement: comparison of three amorphous formulations strategies using different type of polymers. International Journal of Pharmaceutics. doi:10.1016/j.ijpharm.2020.119812

Zinsou, A., Assanhou, G., Ganfon, H., Sounouvou, A. G. H. T., Kassehin, U., Lawson, R., Medegan, S., Evrard, B., & Quetin-Leclercq, J. (2020). Development of new dermatological formulations for the treatment of cutaneous candidiasis. Scientific African, 8, 00342 [1-8. doi:10.1016/j.sciaf.2020.e00342

Bellefroid, C., Lechanteur, A., Evrard, B., Mottet, D., Debacq-Chainiaux, F., & Piel, G. (15 December 2019). In vitro skin penetration enchancement techniques: a combined approach of ethosomes and microneedles. International Journal of Pharmaceutics, 572. doi:10.1016/j.ijpharm.2019.118793

Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (11 December 2019). Lipid-based nanovectors combined with microneedles to enhance skin penetration of genes: in vitro and in vivo studies [Paper presentation]. 2nd CIRM DAY, Liège, Belgium.

Delma, K. L., Semdé, R., Evrard, B., & Piel, G. (11 December 2019). Effects of supercritical carbon dioxide sterilization conditions on physicochemical characteristics of liposomes [Poster presentation]. 2nd CIRM day, Liège, Belgium.

Jennotte, O., Koch, N., Lechanteur, A., & Evrard, B. (11 December 2019). Hot-melt extrusion as a solvent-free technique for the formation of a polymeric amorphous solid dispersion of atorvastatin [Paper presentation]. Second scientific CIRM day, Liège, Belgium.

Koch, N., Jennotte, O., Lechanteur, A., & Evrard, B. (11 December 2019). Improvement of fenofibrate aqueous solubility by using mesoporous silica impregnation under pressurized carbon dioxide [Paper presentation]. 2nd CIRM Day.

Lechanteur, A., Evrard, B., & Piel, G. (11 December 2019). Assessment of the feasibility to develop a fast and easy reproducible 3D bronchial model growing at the air-liquid interface: Which critical culture parameters must be controlled? [Poster presentation]. 2nd CIRM Day.

Nyamba, I., Lechanteur, A., Evrard, B., & SEMDE, R. (11 December 2019). Improvement water-solubility of ellagic acid for use as an antimalarial drug through oral administration [Poster presentation]. CIRM DAY, LIEGE, Belgium.

Penoy, N., Avohou, T. H., Lebrun, P., Evrard, B., & Piel, G. (11 December 2019). A quality by design approach for liposomes production by innovative method using supercritical fluids: which parameters use to obtain good physicochemical characteristics? [Paper presentation]. Second CIRM Scientific Day, Liège, Belgium.

Penoy, N., Avohou, T. H., Lebrun, P., Evrard, B., & Piel, G. (11 December 2019). A quality by design approach for liposomes production by innovative method using supercritical fluids: which parameters use to obtain good physicochemical characteristics? [Paper presentation]. Second CIRM Scientific Day, Liège, Belgium.

Sounouvou, A. G. H. T., Toukourou, H., Lechanteur, A., Piel, G., Quetin-Leclercq, J., Gbaguidi, F., & Evrard, B. (11 December 2019). Development of dermatological dosage forms based on essential oils for the treatment of common skin infections [Paper presentation]. 2nd CIRM day, Liege, Belgium.

Léonard, G., Evrard, B., Grignard, B., & Courard, L. (2019). Plein gaz : enjeux et perspectives de la valorisation du CO2 [Paper presentation]. Rencontre Liège Creative - Réutilisation du CO2, Liège, Belgium.

Sounouvou, A. G. H. T., Lechanteur, A., Quetin-Leclercq, J., Piel, G., Donneau, A.-F., Gbaguidi, F., & Evrard, B. (2019). Chromametric assessment of drug skin tolerance: A comparative study between Africans and Caucasians skins. Skin Research and Technology. doi:10.1111/srt.12804

Delma, K. L., Semdé, R., Evrard, B., & Piel, G. (27 November 2019). Etude de l’influence des conditions de stérilisation par le dioxyde de carbone en phase supercritique (CO2Sc) sur les caractéristiques physicochimiques de liposomes [Paper presentation]. 1ER CONGRES DE LA SOCIETE OUEST AFRICAINE DE PHARMACIE GALENIQUE ET INDUSTRIELLE (SOAPGI), Abidjan, Côte d’Ivoire.

Delma, K. L., Semdé, R., Evrard, B., & Piel, G. (November 2019). Etude de l’influence des conditions de stérilisation par le dioxyde de carbone en phase supercritique (CO2Sc) sur les caractéristiques physicochimiques de liposomes [Poster presentation]. Journées Scientifiques et portes ouvertes de l'Université Joseph KI-ZERBO, Ouagadougou, Burkina Faso.

Nyamba, I., Charles Sombié, Lechanteur, A., Rasmané Semdé, & Evrard, B. (27 October 2019). Amélioration de la solubilité et de la biodisponibilité de l’acide ellagique en vue de son utilisation comme antipaludique [Paper presentation]. Congrès, Abidjan, Côte d’Ivoire.

Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (24 September 2019). Nucleic acids skin penetration enhancement: a combined approach of deformable liposomes and microneedles [Paper presentation]. Skin & Formulation 5th Symposium & 17th Skin Forum, Reims, France.

Dupuis, H., Léonard, G., Detrembleur, C., Evrard, B., & Courard, L. (16 September 2019). Plein Gaz. Le Quinzième Jour, 274.

Rocks, N., Vanwinge, C., Radermecker, C., Blacher, S., Gilles, C., Marée, R., Gillard, A., Evrard, B., Pequeux, C., Marichal, T., Noël, A., & Cataldo, D. (08 September 2019). Ozone-primed neutrophils promote early steps of tumor cell metastasis to lungs by enhancing their NET production [Poster presentation]. IASLC 2019 World Conference on Lung Cancer.

Lechanteur, A., Evrard, B., & Piel, G. (2019). Assessment of the feasibility to develop a fast and easy reproducible 3D bronchial model growing at the air-liquid interface: Which critical culture parameters must be controlled? European Journal of Pharmaceutics and Biopharmaceutics. doi:10.1016/j.ejpb.2019.09.001

Sounouvou, A. G. H. T., Defourny, C., Quetin-Leclercq, J., Gbaguidi, F., Piel, G., & Evrard, B. (September 2019). Silicones in development of a highly persistent sprayable emulsion containing essential oils for treatment of common skin infections [Poster presentation]. Skin and Formulation 5th Symposium & 17th Skin Forum, Reims, France.

Rocks, N., Vanwinge, C., Radermecker, C., Blacher, S., Gilles, C., Marée, R., Gillard, A., Evrard, B., Pequeux, C., Marichal, T., Noël, A., & Cataldo, D. (29 May 2019). Ozone-primed neutrophils promote early steps of tumor cell metastasis to lungs by enhancing their NET production. Thorax, 0, 1-12. doi:10.1136/thoraxjnl-2018-211990

Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (20 May 2019). Improvement of skin penetration of lipid-based nanocarriers according to their composition [Paper presentation]. 20th Forum of Pharmaceutical Sciences, Bruxelles, Belgium.

Jennotte, O., Koch, N., Rocks, N., Lechanteur, A., & Evrard, B. (20 May 2019). Development of new manufacturing processes for amorphous solid dispersions [Paper presentation]. 20th forum of pharmaceutical sciences, Bruxelles, Belgium.

Koch, N., Jennotte, O., Rocks, N., Lechanteur, A., & Evrard, B. (20 May 2019). Mesoporous silica impregnation using supercritical carbon dioxide: is the solubility in the supercritical fluid a critical parameter? [Paper presentation]. 20th Forum of Pharmaceutical Sciences, Bruxelles, Belgium.

Penoy, N., Bigazzi, W., Avohou, T. H., Lebrun, P., Evrard, B., & Piel, G. (20 May 2019). LIPOSOME PRODUCTION BY INNOVATIVE METHOD USING SUPERCRITICAL FLUIDS [Paper presentation]. 20th Forum of Pharmaceutical Sciences, Bruxelles, Belgium.

Sounouvou, A. G. H. T., Quetin-Leclercq, J., Piel, G., Gbaguidi, F., & Evrard, B. (20 May 2019). Assessment of drug skin tolerance in Africans using a chromameter [Paper presentation]. 20th Forum of Pharmaceutical Sciences, Bruxelles, Belgium.

Jennotte, O., Koch, N. (Other coll.), Collard, L. (Other coll.), Lechanteur, A. (Other coll.), & Evrard, B. (Other coll.). (26 March 2019). Hot melt extrusion as a solvent-free technique for the formation of a polymeric amorphous solid dispersion of atorvastatin [Poster presentation]. 3rd European Conference on Pharmaceutics, Bologne, Italy.

Koch, N., Jennotte, O., Rocks, N., Lechanteur, A., & Evrard, B. (26 March 2019). Impregnation of mesoporous silica using supercritical-CO2: is the solubility in the supercritical fluid a critical paramter? [Poster presentation]. 3rd European Conference on Pharmaceutics, Bologne, Italy.

Sounouvou, A. G. H. T., Quetin-Leclercq, J., Piel, G., & Evrard, B. (26 March 2019). Assessment of drug skin tolerance in Africans using chromameter [Poster presentation]. 3rd European Conference on Pharmaceutics, Bologne, Italy.

Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (25 March 2019). Enhancement of skin penetration of lipid-based nanocarriers [Paper presentation]. 3th European Conference on Pharmaceutics, Bologne, Italy.

Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (2019). Lipid gene nanocarriers for the treatment of skin diseases: current state-of-the-art. European Journal of Pharmaceutics and Biopharmaceutics. doi:10.1016/j.ejpb.2019.02.012

Emonts, P., Penoy, N., Rocks, N., Piel, G., Fillet, M., Hubert, P., Ziemons, E., & Evrard, B. (19 January 2019). Update of the progresses and development prospects of the FEDER project Phare [Paper presentation]. CIRM seminars, Liege, Belgium.

Bigazzi, W., Penoy, N., Evrard, B., & Piel, G. (2019). Supercritical fluid methods: an alternative to conventional methods to prepare liposomes. Chemical Engineering Journal. doi:10.1016/j.cej.2019.123106

Palazzo, C., Laloy, J., Delvigne, A. S., Nys, G., Fillet, M., Dogne, J. M., Pequeux, C., Foidart, J.-M., Evrard, B., & Piel, G. (2019). Development of injectable liposomes and drug-in-cyclodextrin-in-liposome formulations encapsulating estetrol to prevent cerebral ischemia of premature babies. European Journal of Pharmaceutical Sciences, 9 (127), 52-59. doi:10.1016/j.ejps.2018.10.006

Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (19 December 2018). Enhancement of skin penetration of lipid-based nanocarriers [Paper presentation]. 1st CIRM Scientific Day, Liège, Belgium.

Jennotte, O., Koch, N., Collard, L., Lechanteur, A., & Evrard, B. (19 December 2018). Hot melt extrusion as a solvent-free technique for the formation of a polymeric amorphous solid dispersion of atorvastatin [Paper presentation]. CIRM Day, Liège, Belgium.

Penoy, N., Bigazzi, W., Piel, G., & Evrard, B. (19 December 2018). Liposome production by innovative method using supercritical fluids [Paper presentation]. 1st CIRM Scientific Day, liege, Belgium.

Koch, N., Jennotte, O., Rocks, N., Lechanteur, A., & Evrard, B. (December 2018). Impregnation of mesoporous silica with fenofibrate using supercritical-CO2: is the solubility a critical parameter? [Paper presentation]. 1st CIRM scientific Day, Liège, Belgium.

Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (August 2018). Assessment of skin penetration of classical and deformable liposomes [Poster presentation]. 12th International Conference and Workshop on Biological Barriers, Saarbrücken, Germany.

Lechanteur, A., Sanna, V., Duchemin, A., Evrard, B., Mottet, D., & Piel, G. (August 2018). Cationic Liposomes Carrying siRNA: Impact of Lipid Composition on Physicochemical Properties, Cytotoxicity and Endosomal Escape [Paper presentation]. 12th International Conference and Workshop on Biological barriers, Saarbruck, Germany.

Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (12 July 2018). Assessment of skin penetration of classical and deformable liposomes [Paper presentation]. First NANOMED EMJMD's Workshop, Paris, France.

Cataldo, D., Evrard, B., Dufour, G., De Tullio, P., & Maes, P. (12 June 2018). Cyclodextrin and Budesonide derivative compositions and methods.

Gallez, A., Palazzo, C., Primac, I., Evrard, B., Noël, A., Piel, G., & Pequeux, C. (24 May 2018). Inclusion of 17β-estradiol into liposome : a tool to study the molecular mechanisms of estrogen receptors [Paper presentation]. 8th Meeting on Nuclear Receptors, Lyon, France.

Lechanteur, A., Sanna, V., Duchemin, A., Evrard, B., Mottet, D., & Piel, G. (2018). Cationic Liposomes Carrying siRNA: Impact of Lipid Composition on Physicochemical Properties, Cytotoxicity and Endosomal Escape. In Cationic liposomes carrying siRNA: impact of lipid composition on physicochemical properties, cytotoxicity and endosomal escape.

Bossens, M., Jost, M., Van Pachterbeke, C., De Maertelaer, V., Simon, P., Frankenne, F., Hubert, P., Evrard, B., & Snoeck, R. (2018). Safety and tolerance of cidofovir as a 2% gel for local application in high-grade cervical intraepithelial neoplasia: A phase 1 investigation. International Journal of Clinical Pharmacology and Therapeutics, 56 (3), 134-141. doi:10.5414/CP203126

Gallez, A., Palazzo, C., Evrard, B., Noël, A., Piel, G., & Pequeux, C. (2018). Liposomal and drug-in cyclodextrin-in-liposome formulations encapsulating 17β-estradiol prevent the activation of the non-genomic effects of estrogen receptor alpha [Paper presentation]. The 18th world congress of Gynecological Endocrinology, Florence, Italy.

Gallez, A., Palazzo, C., Evrard, B., Noël, A., Piel, G., & Pequeux, C. (2018). Inclusion of 17β-estradiol into liposome prevent the activation of membrane initiated signaling of ERalpha [Poster presentation]. EMBO Workshop/ Nuclear receptors and biological networks, Kolymbari, Greece.

Lechanteur, A., Sanna, V., Duchemin, A., Evrard, B., Mottet, D., & Piel, G. (2018). Cationic Liposomes Carrying siRNA: Impact of Lipid Composition on Physicochemical Properties, Cytotoxicity and Endosomal Escape. Nanomaterials, 8 (5). doi:10.3390/nano8050270

Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (07 December 2017). Promoting vaginal distribution of two active siRNA-complexed in liposomes for cervical cancer treatment [Paper presentation]. SF Nano Annual Meeting 2017, Bordeaux, France.

Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (05 December 2017). Promoting vaginal distribution of two active siRNA-complexed in liposomes for cervical cancer treatment [Paper presentation]. 4th SF Nano Annual Meeting, Bordeaux, France.

Cao, M., Karim, R., CATALDO, D., Frederich, M., Evrard, B., & Piel, G. (December 2017). Pulmonary delivery of a liposome formulation encapsulating a natural flavonoid in the treatment of lung cancer [Poster presentation]. Martine Cao, Bordeaux, France.

Karim, R., Palazzo, C., Laloy, J., Delvigne, A.-S., Vanslambrouck, S., Jérôme, C., Lepeltier, E., Orange, F., Dogne, J.-M., Evrard, B., Passirani, C., & Piel, G. (05 November 2017). Development and evaluation of injectable nanosized drug delivery systems for apigenin. International Journal of Pharmaceutics, 532 (2), 757-768. doi:10.1016/j.ijpharm.2017.04.064

Kok, M., Thiry, J., Evrard, B., Nys, G., & Fillet, M. (12 September 2017). Sampling only 10 μL of whole blood to study the bioavailability of itraconazole formulations in rats [Paper presentation]. International Symposium on Electro- and Liquid Phase- Separation Techniques (ITP), Sopot, Poland.

Fillet, M., Thiry, J., Evrard, B., Nys, G., Servais, A.-C., & Kok, M. (September 2017). Blood microsampling for itraconazole pharmacokinetic study on individual rodent in the context of drug formulation optimization [Paper presentation]. Recent Developments in Pharmaceutical Analysis (RDA 2017), Rimini, Italy.

Bigazzi, W., Dufour, G., De Tullio, P., Piel, G., Cataldo, D., & Evrard, B. (June 2017). Interest of cylodextrins in spray-dried microparticles formulation for sustained pulmonary delivery of budesonide [Poster presentation]. EuroDrying’2017 – 6th European Drying Conference, Liège, Belgium.

Pestieau, A., & Evrard, B. (01 May 2017). In vitro biphasic dissolution tests and their suitability for establishing in vitro-in vivo correlations: A historical review. European Journal of Pharmaceutical Sciences, 102, 203-219. doi:10.1016/j.ejps.2017.03.019

Netchacovitch, L., Thiry, J., De Bleye, C., Dumont, E., Cailletaud, J., Sacre, P.-Y., Evrard, B., Hubert, P., & Ziemons, E. (26 April 2017). Global approach for the validation of an in-line Raman spectroscopic method to determine the API content in real-time during a hot-melt extrusion process. Talanta, 171, 45-52. doi:10.1016/j.talanta.2017.04.060

Lechanteur, A., Furst Tania, Evrard, B., Delvenne, P., Hubert, P., & Piel, G. (25 April 2017). Promoting vaginal distribution of two active siRNA-complexed in liposomes for cervical cancer treatment [Paper presentation]. 1st SPLC-Controlled Release Society, Santiago de Compostela, Spain.

Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (04 April 2017). Promoting vaginal distribution of two active siRNA-complexed in liposomes for cervical cancer treatment [Paper presentation]. 2nd European Conference on Pharmaceutics: Drug Delivery, Krakow, Poland.

Thiry, J., Nuozzi, A., Emmerechts, C., Beeckman, E., Krier, F., & Evrard, B. (04 April 2017). Development of an original thermoforming apparatus to be coupled to hot melt extrusion for the continuous production of itraconazole-based amorphous solid dispersions [Paper presentation]. 2nd European Meeting on Pharmaceutics, Krakow, Poland.

Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Piel, G., & Hubert, P. (2017). Promoting vaginal distribution of E7 and MCL-1 siRNA-silencing nanoparticles for cervical cancer treatment. Molecular Pharmaceutics. doi:10.1021/acs.molpharmaceut.6b01154

Pestieau, A., Lebrun, S., Cahay, B., Brouwers, A., Streel, B., Cardot, J.-M., & Evrard, B. (March 2017). Evaluation of different in vitro dissolution tests based on level A in vitro–in vivo correlations for fenofibrate self-emulsifying lipid-based formulations. European Journal of Pharmaceutics and Biopharmaceutics, 112, 18-29. doi:10.1016/j.ejpb.2016.10.030

Thiry, J., Kok, M., Collard, L., Frere, A., Krier, F., Fillet, M., & Evrard, B. (01 March 2017). Bioavailability enhancement of itraconazole-based solid dispersions produced by hot melt extrusion in the framework of the Three Rs rule. European Journal of Pharmaceutical Sciences, 99, 1-8. doi:10.1016/j.ejps.2016.12.001

dos Santos, A., Bayiha, J., Dufour, G., Cataldo, D., Evrard, B., Silva, L. C., Deleu, M., & Mingeot-Leclercq, M.-P. (2017). Changes in biophysical membrane properties induced by the Budesonide/ Hydroxy-β-cyclodextrin complex. Biochimica et Biophysica Acta. Biomembranes. doi:10.1016/j.bbamem.2017.06.010

Frère, A., Baroni, A., Hendrick, E., Delvigne, A. S., Orange, F., Peulen, O., Dakwar, G., Diricq, J., Dubois, P., Evrard, B., Remaut, K., Braeckmans, K., De Smedt, S., Laloy, J., Dogne, J. M., Feller, G., Mespouilles, L., Mottet, D., & Piel, G. (2017). PEGylated and Functionalized Aliphatic Polycarbonate Polyplex Nanoparticles for Intravenous Administration of HDAC5 siRNA in Cancer Therapy. ACS Applied Materials and Interfaces, 25 (9(3)), 2181-2195. doi:10.1021/acsami.6b15064

Karim, R., Lepeltier, E., Palazzo, C., Lépinoux-Chambaud, C., Evrard, B., Eyer, J., Piel, G., & Passirani, C. (2017). Enhancement of the internalization of lipid nanocapsules in human glioblastoma cells: Effect of surface concentration of NFL peptide [Poster presentation]. 11èmes Journées du Cancéropôle Grand Ouest.

Karim, R., Palazzo, C., Lepeltier, E., Lépinoux-Chambaud, C., Evrard, B., Eyer, J., Piel, G., & Passirani, C. (2017). Lipid nanocapsule internalization in U87MG human glioblastoma cells: effect of surface-functionalizing FAM-NFL.TBS-40.63 peptide concentration [Poster presentation]. 3rd CDT in Advanced Therapeutics and Nanomedicines School, 5th NanoFar School.

Netchacovitch, L., Dumont, E., Cailletaud, J., Thiry, J., De Bleye, C., Sacre, P.-Y., Boiret, M., Evrard, B., Hubert, P., & Ziemons, E. (2017). Development of an analytical method for crystalline content determination in amorphous solid dispersions produced by Hot-Melt Extrusion using transmission Raman spectroscopy: A feasibility study. International Journal of Pharmaceutics, 530 (1-2), 249-255. doi:10.1016/j.ijpharm.2017.07.052

Thiry, J., Evrard, B., Nys, G., Fillet, M., & Kok, M. (2017). Sampling only ten microliters of whole blood for the quantification of poorly soluble drugs: Itraconazole as case study. Journal of Chromatography. A, 1479, 161-168. doi:10.1016/j.chroma.2016.12.009

Thiry, J., Krier, F., Ratwatte, S., Thomassin, J.-M., Jérôme, C., & Evrard, B. (01 January 2017). Hot-Melt Extrusion as a Continuous Manufacturing Process to Form Ternary Cyclodextrin Inclusion Complexes. European Journal of Pharmaceutical Sciences, 96, 590-597. doi:10.1016/j.ejps.2016.09.032

Thiry, J., Lebrun, P., Vinassa, C., Adam, M., Netchacovitch, L., Ziemons, E., Hubert, P., Krier, F., & Evrard, B. (30 December 2016). Continuous Production of Itraconazole-based Solid Dispersions by Hot Melt Extrusion: Preformulation, Optimization and Design Space Determination. International Journal of Pharmaceutics, 515 (1-2), 114-124. doi:10.1016/j.ijpharm.2016.10.003

Karim, R., Palazzo, C., Laloy, J., Lepeltier, E., Delvigne, A.-S., Dogne, J.-M., Evrard, B., Passirani, C., & Piel, G. (December 2016). Development and comparison of liposomes and nanocapsules as injectable nanocarriers for poorly aqueous soluble drugs [Poster presentation]. Journées annuelles SFNano, Paris 2016, Paris, France.

Palazzo, C., Laloy, J., Delvigne, A.-S., Nys, G., Dogne, J.-M., Fillet, M., Foidart, J.-M., Evrard, B., & Piel, G. (December 2016). NEW INJECTABLE LIPOSOME AND DRUG-IN-CYCLODEXTRIN-IN LIPOSOME SYSTEMS ENCAPSULATING ESTETROL FOR THE TREATMENT OF ISCHEMIA DISEASES IN PREMATURE BABIES [Poster presentation]. Journées annuelles SFNano, Paris 2016, Paris, France.

Thiry, J., Krier, F., Ratwatte, S., Thomassin, J.-M., Jérôme, C., & Evrard, B. (16 November 2016). Hot-Melt Extrusion as a Continuous Manufacturing Process to Form Ternary Cyclodextrin Inclusion Complexes [Poster presentation]. AAPS 2016 Denver.

Thiry, J., Kok, M., Collard, L., Frère, A., Krier, F., Fillet, M., & Evrard, B. (15 November 2016). Original study of the bioavailability enhancement of itraconazole-based solid dispersions produced by hot melt extrusion in the framework of the three Rs rule [Poster presentation]. AAPS 2016 Denver.

Bigazzi, W., Dufour, G., Mingeot-Leclercq, M.-P., Cataldo, D., & Evrard, B. (17 October 2016). Dry powder of budesonide/hydroxypropyl-beta-cyclodextrin complex for inhalation as a new potential antiasthmatic treatment [Paper presentation]. 19th Forum of Pharmaceutical Sciences, Bruxelles, Belgium.

Netchacovitch, L., Thiry, J., De Bleye, C., Dumont, E., Sacre, P.-Y., Evrard, B., Hubert, P., & Ziemons, E. (17 October 2016). Determination of the analytical performances of an in-line Raman spectroscopic method monitoring a hot-melt extrusion process [Paper presentation]. 19th Forum of Pharmaceutical Sciences, Bruxelles, Belgium.

Palazzo, C., Laloy, J., Delvigne, A.-S., Nys, G., Dogne, J.-M., Karim, R., Fillet, M., Foidart, J.-M., Evrard, B., & Piel, G. (28 September 2016). INNOVATIVE INJECTABLE LIPOSOME AND DRUG-IN-CYCLODEXTRIN-IN LIPOSOME SYSTEMS ENCAPSULATING ESTETROL FOR THE TREATMENT OF ISCHEMIA DISEASES IN PREMATURE BABIES [Paper presentation]. 4th Congress on Innovation in Drug Delivery, Antibes-Juan-Les-Pins, France.

Karim, R., Palazzo, C., Laloy, J., Delvigne, A. S., Dogne, J. M., Passirani, C., Evrard, B., & Piel, G. (27 September 2016). DEVELOPMENT OF NOVEL CATIONIC AND LIGAND-GRAFTED ANIONIC LIPOSOMES FOR BRAIN-TARGETED DRUG DELIVERY [Poster presentation]. 4th Conference on Innovation in Drug Delivery: Site specific drug delivery, Antibes, France.

Lechanteur, A., Furst, T., Evrard, B., DELVENNE, P., Hubert, P., & Piel, G. (27 September 2016). FINDING THE RIGHT BALANCE BETWEEN EFFECTIVENESS, TOXICITY AND VAGINAL DIFFUSION OF siRNA LIPOPLEXES FOR CERVICAL CANCER TREATMENT [Poster presentation]. 4th Conference on Innovation in Drug Delivery: Site specific drug delivery, Antibes, France.

Furst, T., Dakwar, G., zagato, E., Lechanteur, A., Remaut, K., Evrard, B., De Smedt, S., & Piel, G. (26 September 2016). MUCOADHESIVE SPONGES WITH PEGYLATED LIPOPLEXES: TOWARDS A SUSTAINED VAGINAL DELIVERY OF siRNA [Poster presentation]. 4th Conference on Innovation in Drug Delivery: Site specific drug delivery, Antibes, France.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Hubert, P., & Piel, G. (August 2016). PEGylation of lipoplexes: The right balance between cytotoxicity and siRNA effectiveness. European Journal of Pharmaceutical Sciences, 93, 493-593. doi:10.1016/j.ejps.2016.08.058

Frère, A., Evrard, B., Mottet, D., & Piel, G. (2016). Polymeric Nanoparticles as siRNA Drug Delivery System for Cancer Therapy: The Long Road to Therapeutic Efficiency. In A. M. Holban & A. Grumezescu (Eds.), Nanoarchitectonics for Smart Delivery and Drug Targeting (pp. 503-540). Elsevier. doi:10.1016/B978-0-323-47347-7.00018-5

Furst, T., Bettonville, V., Farcas, E., Frère, A., Lechanteur, A., Evrard, B., Fillet, M., Piel, G., & Servais, A.-C. (2016). Capillary electrophoresis method to determine siRNA complexation with cationic liposomes. Electrophoresis. doi:10.1002/elps.201600249

Netchacovitch, L., Thiry, J., De Bleye, C., Dumont, E., Dispas, A., Hubert, C., Krier, F., Sacre, P.-Y., Evrard, B., Hubert, P., & Ziemons, E. (July 2016). A simple calibration approach based on film-casting for confocal Raman microscopy to support the development of a Hot-Melt Extrusion process. Talanta, 154, 392-399. doi:10.1016/j.talanta.2016.03.080

Evrard, B. (16 June 2016). Pharmaceutical applications of supercritical fluids [Paper presentation]. Séminaire du CIRM.

Furst, T., Dakwar, G. R., Zagato, E., Lechanteur, A., Remaut, K., Evrard, B., Braeckmans, K., & Piel, G. (2016). Freeze-dried mucoadhesive polymeric system containing pegylated lipoplexes: Towards a vaginal sustained released system for siRNA. Journal of Controlled Release. doi:10.1016/j.jconrel.2016.06.028

Grimard, J., Dewasme, L., Thiry, J., Krier, F., Evrard, B., & Vande Wouwer, A. (June 2016). Modeling, sensitivity analysis and parameter identification of a twin screw extruder [Paper presentation]. 11th IFAC Symposium on Dynamics and Control of Process Systems, including Biosystems.

Thiry, J., Krier, F., Ratwatte, S., Thomassin, J.-M., Jérôme, C., & Evrard, B. (06 April 2016). Hot Melt Extrusion as a New Method to Form Inclusion Complexes with Cyclodextrins [Paper presentation]. 10th PBP World Meeting, Glasgow, United Kingdom.

Karim, R., Palazzo, C., Dubois, N., Bours, V., Passirani, C., & Evrard, B. (April 2016). Development of injectable liposomes entrapping apigenin for brain-targeted delivery as glioblastoma treatment [Poster presentation]. 10th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology.

Karim, R., Palazzo, C., Evrard, B., & Piel, G. (16 February 2016). Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art. Journal of Controlled Release, 10 (227), 23-37. doi:10.1016/j.jconrel.2016.02.026

Palazzo, C., Karim, R., Evrard, B., & Piel, G. (2016). DRUG DELIVERY NANOCARRIERS TO CROSS OF THE BLOOD-BRAIN BARRIER. In A. Grumezescu (Ed.), Nanobiomaterials in drug delivery. Elsevier. doi:10.1016/B978-0-323-42866-8.00001-0

Pestieau, A., Krier, F., Brouwers, A., Streel, B., & Evrard, B. (2016). Selection of a discriminant and biorelevant in vitro dissolution test for the development of fenofibrate self-emulsifying lipid-based formulations. European Journal of Pharmaceutical Sciences. doi:10.1016/j.ejps.2016.04.038

Thiry, J., Broze, G., Pestieau, A., Tatton, A., Baumans, F., Damblon, C., Krier, F., & Evrard, B. (2016). Investigation of a suitable in vitro dissolution test for itraconazole-based solid dispersions. European Journal of Pharmaceutical Sciences. doi:10.1016/j.ejps.2016.02.002

Frère, A., Baroni, A., Peulen, O., Orange, F., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (December 2015). Pegylated Polyplexes Based On HDAC5 siRNA And Aliphatic Polycarbonate Polymers For An Anticancer Therapy [Poster presentation]. European Nanomedicine Meeting, Grenoble, France.

Frère, A., Baroni, A., Peulen, O., Orange, F., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (23 November 2015). Pegylated Polyplexes Based On HDAC5 siRNA And Aliphatic Polycarbonate Polymers For An Anticancer Therapy [Poster presentation]. Biopharmacy Day, Leuven, Belgium.

Thiry, J., Lebrun, P., Netchacovitch, L., Ziemons, E., Hubert, P., Krier, F., & Evrard, B. (23 November 2015). Production of Itraconazole/Soluplus® Extrudates: Optimization of Both Formulation and Hot-Melt Extrusion Process Through a Single Design of Experiment [Paper presentation]. Biopharmacy Day 2015, Leuven, Belgium.

Pestieau, A., Lebrun, S., Cahay, B., & Evrard, B. (28 October 2015). In vitro and in vivo evaluation of an optimized fenofibrate lipid based solid dispersion produced by a PGSS process [Paper presentation]. 2015 AAPS Annual Meeting and Exposition, Orlando, United States.

Pestieau, A., Lebrun, S., Cahay, B., & Evrard, B. (28 October 2015). In vitro and in vivo evaluation of an optimized fenofibrate lipid based solid dispersion produced by a PGSS process [Poster presentation]. 2015 AAPS Annual Meeting and Exposition, Orlando, United States.

Palazzo, C., Karim, R., Furst, T., Pequeux, C., Tskitishvili, E., Mawet, M., Maillard, C., Foidart, J.-M., Evrard, B., & Piel, G. (25 October 2015). LIPOSOME ENCAPSULATING ESTETROL FOR THE TREATMENT OF ISCHEMIA DISEASES IN PREMATURE BABIES [Poster presentation]. 2015 AAPS Annual Meeting and Exposition, Orlando, FLA, United States.

Thiry, J., Lebrun, P., Netchacovitch, L., Pestieau, A., Ziemons, E., Hubert, P., Krier, F., & Evrard, B. (October 2015). Production of Itraconazole/Soluplus® Extrudates: Optimization of Both Formulation and Hot-Melt Extrusion Process Through a Single Design of Experiment [Poster presentation]. AAPS Orlando 2015.

Karim, R., Palazzo, C., Dubois, N., Bours, V., Passirani, C., Evrard, B., & Piel, G. (08 September 2015). Stealth Liposome and Drug-In-Cyclodextrin-In-Liposome Formulations Entrapping Apigenin as Novel Therapy for Glioblastoma [Poster presentation]. 'From drug development to target drug'- UniGR workshop on Biomedicine, Arlon, Belgium.

Frère, A., Tempelaar, S., Peulen, O., Evrard, B., Dubois, P., Mottet, D., & Piel, G. (September 2015). Polyplexes Based on Polycarbonate Polymers and HDAC5 siRNA Efficiently Decrease the Proliferation of Cancer Cells [Poster presentation]. UniGR biomedecine workshop, Arlon, Belgium.

Netchacovitch, L., Thiry, J., De Bleye, C., Chavez, P.-F., Krier, F., Sacre, P.-Y., Evrard, B., Hubert, P., & Ziemons, E. (September 2015). Vibrational spectroscopy and microspectroscopy analyzing qualitatively and quantitatively pharmaceutical hot melt extrudates. Journal of Pharmaceutical and Biomedical Analysis, 113, 21-33. doi:10.1016/j.jpba.2015.01.051

Frère, A., Tempelaar, S., Peulen, O., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (02 June 2015). Polyplex Based on Polycarbonate Polymers for an Efficient Delivery of HDAC5 and HDAC7 siRNA [Poster presentation]. Biomedica 2015, Genk, Belgium.

Palazzo, C., Karim, R., Pequeux, C., Tskitishvili, E., Mawet, M., Maillard, C., Foidart, J.-M., Evrard, B., & Piel, G. (02 June 2015). Liposome Encapsulating Estetrol For The Treatment Of Ischemia Diseases In Prematures Babies [Poster presentation]. Biomedica 2015, Genk, Belgium.

Chavez, P.-F., Lebrun, P., Sacre, P.-Y., De Bleye, C., Netchacovitch, L., Cuypers, S., Mantanus, J., Motte, H., Schubert, M., Evrard, B., Hubert, P., & Ziemons, E. (30 May 2015). Optimization of a Pharmaceutical Tablet Formulation based on a Design Space Approach and using Vibrational Spectroscopy as PAT Tool. International Journal of Pharmaceutics, 486 (1-2), 13-20. doi:10.1016/j.ijpharm.2015.03.025

Pestieau, A., Krier, F., Lebrun, P., & Evrard, B. (29 May 2015). Optimization of a PGSS process for a fenofibrate lipid-based solid dispersion formulation [Paper presentation]. 18th Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Frère, A., Evrard, B., Mottet, D., & Piel, G. (28 May 2015). Polyplex Based on Polycarbonate Polymers for an Efficient Delivery of HDAC5 and HDAC7 siRNA [Paper presentation]. 18th Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (28 May 2015). DEVELOPMENT OF LIPOPLEXES FOR A TOPICAL TREATMENT OF HPV16 INDUCED LESIONS: In vitro and ex vivo studies [Paper presentation]. 18th Forum of Pharmaceutical Sciences, Blankenberg, Belgium.

Netchacovitch, L., Thiry, J., De Bleye, C., Chavez, P.-F., Krier, F., Sacre, P.-Y., Evrard, B., Hubert, P., & Ziemons, E. (21 May 2015). Analysis of film casting by Raman confocal microscopy: An innovative approach in the framework of drug content and API solid-state determination [Paper presentation]. Forum des jeunes chercheurs, Namur, Belgium.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (13 May 2015). Anti-E6/E7/MCL1 pegylated lipoplexes for a topical treatment of HPV16 induced lesions [Paper presentation]. GIGA-Cancer Day 2015, Liege, Belgium.

Thiry, J., Pestieau, A., Krier, F., & Evrard, B. (May 2015). How to choose a suitable dissolution test for BCS II drugs? [Paper presentation]. 18e Forum des Sciences Pharmaceutiques.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (14 April 2015). Anti-E6/E7/MCL1 pegylated lipoplexes for a vaginal treatment of cervical cancer [Paper presentation]. 1st European Conference on Pharmaceutics Drug Delivery, Reims, France.

Palazzo, C., Karim, R., Mawet, M., Maillard, C., Foidart, J.-M., Evrard, B., & Piel, G. (14 April 2015). LIPOSOME CONTAINING ESTETROL FOR THE TREATMENT OF ISCHEMIA DISEASES IN PREMATURE BABIES [Poster presentation]. 1st European Conference on Pharmaceutics, Reims, France.

Furst, T., Lechanteur, A., Evrard, B., & Piel, G. (13 April 2015). Mucoadhesive hydroxyethyl-cellulose sponges as lipoplexes delivery system for vaginal application [Poster presentation]. 1st European Conference on Pharmaceutics: Drug Delivery, Reims, France.

Zime-Diawara, H., Sissinto-Savi de Tove, Y., Akogbeto, O. E., Ogouyemi-Hounto, A., Gbaguidi, F., kinde-Gazard, D., Massougbodji, A., Bigot, A., Sinsin, B., Quetin-Leclercq, J., Evrard, B., & Moudachirou, M. (April 2015). Etude de l’efficacité et de la tolérance d’une tisane à base de Artemisia annua L. (Asteraceae) cultivée au Bénin pour la prise en charge du paludisme simple. International Journal of Biological and Chemical Sciences, 9 (2), 692-702.

Pestieau, A., Krier, F., Lebrun, P., Brouwers, A., Streel, B., & Evrard, B. (18 March 2015). Optimization of a PGSS (particles from gas saturated solutions) process for a fenofibrate lipid-based solid dispersion formulation. International Journal of Pharmaceutics, 485, 295-305. doi:10.1016/j.ijpharm.2015.03.027

Lechanteur, A.* , Furst, T.* , Evrard, B., Delvenne, P., Hubert, P., & Piel, G. (16 February 2015). Development of anti-E6 pegylated lipoplexes for mucosal application in the context of cervical preneoplastic lesions. International Journal of Pharmaceutics, 483, 268-277. doi:10.1016/j.ijpharm.2015.02.041
* These authors have contributed equally to this work.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (11 February 2015). Anti-E6/E7/MCL1 pegylated lipoplexes for a topical treatment of cervical (pre)neoplastic lesions [Poster presentation]. Séminaire des chercheurs Télévie 2015, Bruxelles, Belgium.

Thiry, J., Krier, F., & Evrard, B. (01 February 2015). A Review of Pharmaceutical Extrusion: Critical Process Parameters and Scaling-up. International Journal of Pharmaceutics, 479 (1), 227-240. doi:10.1016/j.ijpharm.2014.12.036

Furst, T., Piette, M., Lechanteur, A., Evrard, B., & Piel, G. (2015). Mucoadhesive cellulosic derivative sponges as drug delivery system for vaginal application. European Journal of Pharmaceutics and Biopharmaceutics. doi:10.1016/j.ejpb.2015.01.019

Dufour, G., Bigazzi, W., Wong, N., Boschini, F., De Tullio, P., Piel, G., CATALDO, D., & Evrard, B. (2015). Interest of cyclodextrins in spray-dried microparticles formulation for sustained pulmonary delivery of budesonide. International Journal of Pharmaceutics, 495 (2), 869-878. doi:10.1016/j.ijpharm.2015.09.052

Dufour, G., Evrard, B., & De Tullio, P. (2015). Rapid quantification of 2-hydroxypropyl-β-cyclodextrin in liquid pharmaceutical formulations by 1H nuclear magnetic resonance spectroscopy. European Journal of Pharmaceutical Sciences. doi:10.1016/j.ejps.2015.03.005

Dufour, G.* , Evrard, B.* , & De Tullio, P.*. (2015). 2D-COSY NMR spectroscopy as a quantitative tool in biological matrix: Application to cyclodextrins. AAPS Journal. doi:10.1208/s12248-015-9806-9
* These authors have contributed equally to this work.

Dufour, G., Piel, G., & Evrard, B. (2015). Utilisation et caractérisation des complexes de cyclodextrines dans les formulations à usage pharmaceutique. In N. Morin-Crini, S. Fourmentin, ... G. Crini, Cyclodextrines: Histoire, propriétés, chimie et applications. Presses universitaires de Franche-Comté.

Frère, A., Kawalec, M., Tempelaar, S., Peixoto, P., Hendrick, E., Peulen, O., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (2015). Impact of the Structure of Biocompatible Aliphatic Polycarbonates on siRNA Transfection Ability. Biomacromolecules. doi:10.1021/bm501676p

Karim, R., Palazzo, C., Dubois, N., Frère, A., Bours, V., Passirani, C., Evrard, B., & Piel, G. (2015). Design of Liposomes Entrapping Apigenin- A Novel Approach for Glioblastoma Therapy [Poster presentation]. 2015 AAPS Annual Meeting and Exposition, Orlando, United States.

Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (2015). Anti-E6/E7/MCL-1 pegylated lipoplexes for a vaginal treatment of cervical cancer [Paper presentation]. 1st European Conference on Pharmaceutics: Drug Delivery, Reims, France.

Netchacovitch, L., Thiry, J., De Bleye, C., Chavez, P.-F., Sacre, P.-Y., Krier, F., Evrard, B., Hubert, P., & Ziemons, E. (January 2015). Confocal Raman microscopy to support the development of an extrusion process: a quantitative approach based on film casting [Poster presentation]. CHimiometrie XVI, Genève, Switzerland.

Thiry, J., Netchacovitch, L., Krier, F., Ziemons, E., Hubert, P., & Evrard, B. (2015). Determination of the Crystal Content within an Itraconazole-based extrudate : Comparison between Differential Scanning Calorimetry and Raman techniques [Poster presentation]. TA Instruments' BeNeLux Users Meeting & Symposium 2015.

Frère, A., Evrard, B., Mespouille, L., Mottet, D., & Piel, G. (12 December 2014). Polyplex based on polycarbonate polymers for an efficient delivery of HDAC5 and HDAC7 siRNA [Paper presentation]. Biopharmacy Day, Vlaardingen, Netherlands.

Palazzo, C., Karim, R., Mawet, M., Maillard, C., Foidart, J.-M., Evrard, B., & Piel, G. (12 December 2014). Estetrol and cyclodextrin-estetrol loaded liposomes for the treatment of ischemia diseases in premature babies [Poster presentation]. Biopharmacy Day, Vlaardingen, Netherlands.

Pestieau, A., Krier, F., & Evrard, B. (12 December 2014). Optimization of a PGSS manufacturing process of a lipid-based solid dispersion containing a BCS II API [Paper presentation]. Meeting of the Belgian-Dutch Biopharmaceutical Society, Vlaardingen, Netherlands.

Thiry, J., Krier, F., Pestieau, A., & Evrard, B. (December 2014). Selection of a Discriminant Dissolution Test for Extrudates Containing Itraconazole [Poster presentation]. Biopharmacy Day 2014, Vlaardingen, Netherlands.

Thiry, J., Krier, F., Pestieau, A., & Evrard, B. (06 November 2014). Preformulation Study of an Itraconazole-based Oral Dosage Produced by Hot-Melt Extrusion [Poster presentation]. AAPS Annual Meeting San Diego 2014.

Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (03 November 2014). DEVELOPMENT AND CHARACTERIZATION OF PEGYLATED LIPOPLEXES TO BE ENTRAPPED IN HEC SPONGES FOR VAGINAL DELIVERY [Poster presentation]. 2014 AAPS Annual Meeting and Exposition, San Diego, United States.

Thiry, J., Krier, F., Pestieau, A., & Evrard, B. (03 November 2014). Selection of a Discriminant Dissolution Test for Itraconazole-based Extrudates [Poster presentation]. AAPS Annual Meeting San Diego 2014.

Pestieau, A., & Evrard, B. (November 2014). Development of a biphasic in vitro dissolution test for the study of a BCS II API lipid based oral dosage form produced by a PGSS process [Poster presentation]. 2014 AAPS Annual Meeting and Exposition, San Diego, United States.

Pestieau, A., Krier, F., Lebrun, P., & Evrard, B. (November 2014). Optimization of a PGSS manufacturing process of a lipid based solid dispersion of a BCS II API [Poster presentation]. 2014 AAPS Annual Meeting and Exposition, San Diego, United States.

Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (20 October 2014). DEVELOPMENT AND CHARACTERIZATION OF PEGYLATED LIPOPLEXES TO BE ENTRAPPED IN HEC SPONGES FOR VAGINAL DELIVERY [Poster presentation]. 3rd NanoFar Autumn School, Louvain, Belgium.

Lechanteur, A., Furst, T., Kanber, E., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (04 October 2014). Development and optimization of pegylated lipoplexes for vaginal application [Paper presentation]. SFNano Workshop 2014, Porto, Portugal.

Thoorens, G., Krier, F., Leclercq, B., Carlin, B., & Evrard, B. (01 October 2014). Microcrystalline cellulose, a direct compression binder in a quality by design environment—A review. International Journal of Pharmaceutics, 473 (1-2), 64-72. doi:10.1016/j.ijpharm.2014.06.055

Frère, A., Tempelaar, S., Peixoto, P., Peulen, O., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (28 August 2014). Polyplex based on polycarbonate polymesr for an efficient delivery of an anti-angiogenic siRNA [Paper presentation]. Translational Nanomedicine, Angers, France.

Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (27 August 2014). DEVELOPMENT OF PEG-COATED LIPOPLEXES TO BE INCORPORATED INTO MUCOADHESIVE HEC-SPONGES [Poster presentation]. Translational Nanomedicine, International Meeting, Angers, France.

LAMBERT, V., Dufour, G., Chiap, P., Evrard, B., Noël, A., Pirotte, B., & De Tullio, P. (23 June 2014). NMR in the Pharmaceutical and Biomedical areas for identification and quantification of drugs and metabolomics applications [Paper presentation]. Drug Analysis 2014, Liège, Belgium.

Chavez, P.-F., Netchacovitch, L., Sacre, P.-Y., De Bleye, C., Lebrun, P., Motte, H., Schubert, M., Evrard, B., Hubert, P., & Ziemons, E. (June 2014). Optimization of a Pharmaceutical Tablet Formulation using a Design Space Approach and Vibrational Spectroscopy as PAT Tool [Poster presentation]. Drug Analysis 2014, Liège, Belgium.

Dufour, G., Evrard, B., & De Tullio, P. (June 2014). Quantification of 2-hydroxypropyl-β-cyclodextrin in liquid pharmaceutical formulations by using 1H Nuclear Magnetic Resonance spectroscopy [Poster presentation]. 10th International Symposium on Drug Analysis; 25th International Symposium on Pharmaceutical and Biomedical Analysis.

Netchacovitch, L., Thiry, J., De Bleye, C., Sacre, P.-Y., Chavez, P.-F., Krier, F., Evrard, B., Hubert, P., & Ziemons, E. (June 2014). Confocal Raman microscopy to support the development of an extrusion process by qualitative and quantitative analyses [Poster presentation]. Drug Analysis 2014.

Pestieau, A., Krier, F., Thoorens, G., Dupont, A., Chavez, P.-F., Ziemons, E., Hubert, P., & Evrard, B. (June 2014). Towards a real time release approach for manufacturing tablets using NIR spectroscopy [Poster presentation]. Drug Analysis 2014, Liège, Belgium.

Frère, A., Kawalec, M., Tempelaar, S., Peixoto, P., Peulen, O., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (26 May 2014). Impact of the Structure of Biocompatible Aliphatic Polycarbonate on siRNA Transfection Ability [Poster presentation]. Advanced Functional Polymers for Medicine AFPM) 2014, Liège, Belgium.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (19 May 2014). ASSOCIATION OF LIPOSOMES AND siRNA FOR A LOCAL TREATMENT OF CERVICAL CANCER [Poster presentation]. GIGA-Cancer Day 2014.

Pestieau, A., Krier, F., Thoorens, G., Dupont, A., Chavez, P.-F., Ziemons, E., Hubert, P., & Evrard, B. (May 2014). Towards a real time release approach for manufacturing tablets using NIR spectroscopy. Journal of Pharmaceutical and Biomedical Analysis, 98, 60-67. doi:10.1016/j.jpba.2014.05.002

Thiry, J., Krier, F., Pestieau, A., & Evrard, B. (May 2014). Production of Itraconazole-based Solid Dispersions Using Hot-Melt Extrusion [Poster presentation]. AFPM 2014, Liège, Belgium.

Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (03 April 2014). DEVELOPMENT OF PEG-COATED LIPOPLEXES WITH siRNA ANTI E6/E7 ONCOPROTEINS FOR THE TREATMENT OF HPV CANCERS [Poster presentation]. 9th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Lisbonne, Portugal.

Dufour, G., Evrard, B., & De Tullio, P. (April 2014). Detection and quantification of 2-hydroxypropyl-β-cyclodextrin in solution by 1H NMR spectroscopy as a tool for quality control [Poster presentation]. 9TH WORLD MEETING on Pharmaceutics, Biopharmaceuticsand Pharmaceutical Technology.

Frère, A., Peixoto, P., Kawalec, M., Evrard, B., Mespouille, L., Mottet, D., & Piel, G. (April 2014). Polyplexes Targeting Angiogenesis in Cancer [Poster presentation]. 9th World Meeting on Pharmaceutics, Biopharmaceuticsand Pharmaceutical Technology, Lisbon, Portugal.

Cataldo, D., Evrard, B., Dufour, G., De Tullio, P., & Maes, P. (28 March 2014). Compositions of Cyclodextrin with Budesonide Derivatives and Methods.

Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (16 February 2014). Development of PEG-coated lipoplexes with siRNA anti-E6/E7 oncoproteins to be incorporated into mucoadhesive HEC-sponges for the treatment of HPV cancers [Poster presentation]. 10th International Conference and Workshop on Biological Barriers, Saarbrucken, Germany.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (16 February 2014). Development of anti-HPV lipoplexes formulations for the treatment of cervical cancer [Poster presentation]. 10th International conference and workshop on Biological Barriers.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (27 January 2014). Development of anti-HPV lipoplexes formulations for the treatment of cervical cancer [Poster presentation]. GIGA-Day 2014.

Cataldo, D., Evrard, B., Dufour, G., De Tullio, P., & Maes, P. (2014). Composition of Cyclodextrin with Budesonide Derivatives for treatment and Prevention of Pulmonary Inflammatory Disease.

Frère, A., Kawalec, M., Tempelaar, S., Peixoto, P., Peulen, O., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (2014). Polyplex Based On Polycarbonate Polymers For An Efficient Delivery Of An Anti-Angiogenic siRNA [Poster presentation]. 3rd NanoFar Autumn School, Brussels, Belgium.

Frère, A., Krier, F., Evrard, B., Mottet, D., & Piel, G. (2014). Polyplex Based On Polycarbonate Polymers For An Efficient Delivery Of An Anti-Angiogenic siRNA [Poster presentation]. 2014 AAPS Annual Meeting and Exposition, San Diego, United States.

Krier, F., Riva, R., Defrère, S., Mestdagt, M., Van Langendonckt, A., Drion, P., Dehoux, J.-P., Donnez, J., Foidart, J.-M., Jérôme, C., & Evrard, B. (2014). Device-based controlled local delivery of anastrozol into peritoneal cavity: in vitro and in vivo evaluation. Journal of Drug Delivery Science and Technology, 24 (2), 198-204. doi:10.1016/S1773-2247(14)50032-9

Mehuys, E., Paemeleire, K., Van Hees, T., Christiaens, T., Van Bortel, L., Van Tongelen, I., Philippe, G., Prévôt, M.-L., Evrard, B., Piette, M., De Bolle, L., Remon, J., & Boussery, K. (2014). Zelfbehandeling van frequente hoofdpijn : een Belgische apotheekstudie [Paper presentation]. Prisma Symposium, Amersfoort, Netherlands.

Pestieau, A., & Evrard, B. (2014). EVALUATION OF THE POTENTIALITIES OF A BIPHASIC IN VITRO DISSOLUTION TEST FOR THE STUDY OF ORAL DOSAGE FORMS CONTAINING BCS II API COMPARED TO CONVENTIONAL SINGLE PHASE METHODS [Poster presentation]. 9th PBP World Meeting, Lisbonne, Portugal.

Thiry, J., Krier, F., Pestieau, A., & Evrard, B. (2014). Production Of Itraconazole-based Solid Dispersions Using Hot-Melt Extrusion: Preformulation Study [Poster presentation]. 9th PBP World Meeting Lisbon 2014.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., RONCARATI, P., Piel, G., & Hubert, P. (05 December 2013). Development of anti-HPV lipoplexes formulations for the treatment of cervical cancer [Poster presentation]. Séminaire des chercheurs du Télévie 2014.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (03 December 2013). Development of anti-HPV lipoplexes for the treatment of cervical cancer [Paper presentation]. 28ième Journées Scientifiques du GTRV, Angers, France.

Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (02 December 2013). Development of peggylated lipoplexes with siRNA anti-E6/E7 oncoproteins for the treatment og cancers induced by HPV [Poster presentation]. GTRV, Orléans, France.

Frère, A., Kawalec, M., Peixoto, P., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (December 2013). The intracellular fate of polycarbonate Polyplexes modulates the efficacy of siRNA [Poster presentation]. 28th GTRV annual meeting, Orleans, France.

Pestieau, A., Krier, F., Thoorens, G., Dupont, A., Chavez, P.-F., Ziemons, E., Hubert, P., & Evrard, B. (November 2013). Real time release approach in terms of four Pharmacopoeia tests for tablets manufacturing using NIR spectroscopy [Poster presentation]. AAPS Annual Meeting and Exposition, San Antonio, United States.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (17 October 2013). Development of anti-HPV lipoplexes for the treatment of cervical cancer [Paper presentation]. Dix-septième forum des sciences pharmaceutiques.

Pestieau, A., & Evrard, B. (October 2013). Evaluation of biphasic in vitro dissolution test potential interest for BCS clas II active pharmaceutical ingredients compared to conventional methods [Paper presentation]. 17th Forum of Pharmaceutical Sciences, Spa, Belgium.

Chavez, P.-F., Netchacovitch, L., Sacre, P.-Y., De Bleye, C., Lebrun, P., Motte, H., Evrard, B., Hubert, P., & Ziemons, E. (September 2013). Application of a Design Space Approach for a Pharmaceutical Tablet Formulation Optimization based on a Mixture Design of Experiments and using Vibrational Spectroscopy as PAT Tool [Poster presentation]. EuPAT 6 - Sixth pan-European QbD & PAT Science Conference, Porto, Portugal.

Riva, R., Krier, F., Defrère, S., Mestdagt, M., Van Langendonckt, A., Drion, P., Donnez, J., Dehoux, J.-P., Foidart, J.-M., Evrard, B., & Jérôme, C. (18 August 2013). Device-based controlled local delivery for the treatment of peritoneal pathologies [Poster presentation]. Advanced Polymers via Macromolecular Engineering (APME), Durham, United Kingdom.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (17 June 2013). Développement et optimisation de vecteur de type lipoplexe pour une approche thérapeutique antisens dans le cadre de lésions induites par HPV [Paper presentation]. Séminaire C.I.R.M.

Chavez, P.-F., Netchacovitch, L., Sacre, P.-Y., De Bleye, C., Pestieau, A., Krier, F., Mantanus, J., Motte, H., Schubert, M., Evrard, B., Hubert, P., & Ziemons, E. (June 2013). Optimization of a Pharmaceutical Tablet Formulation: Screening Experiments using Vibrational Spectroscopy as PAT Tool [Poster presentation]. 2013 AAPS Annual Meeting and Exposition, San Antonio, United States - Texas.

Krier, F., Mantanus, J., Sacre, P.-Y., Chavez, P.-F., Thiry, J., Pestieau, A., Rozet, E., Ziemons, E., Hubert, P., & Evrard, B. (2013). PAT tools for the control of co-extrusion implants manufacturing process. International Journal of Pharmaceutics, 458, 15-24. doi:10.1016/j.ijpharm.2013.09.040

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., RONCARATI, P., Piel, G., & Hubert, P. (2013). Development of anti-HPV lipoplexes for the treatment of cervical cancer [Poster presentation]. Cancer GIGA-Day 2013, liège, Belgium.

Reschner, A., Shim, Y. H., Dubois, P., Delvenne, P., Evrard, B., Marcelis, L., Moucheron, C., Kirsch-De Mesmaeker, A., Defrancq, E., Raes, M., Piette, J., Collard, L., & Piel, G. (2013). Evaluation of a new biocompatible poly(N-(morpholino ethyl methacrylate)-based copolymer for the delivery of ruthenium oligonucleotides, targeting HPV16 E6 oncogene. Journal of Biomedical Nanotechnology, 9, 1-9. doi:10.1166/jbn.2013.1634

Thiry, J., Krier, F., Pestieau, A., & Evrard, B. (2013). Preformulation study of an itraconazole-based drug using hot-melt extrusion [Paper presentation]. 17ème Forum des Sciences Pharmaceutiques.

Zime-Diawara, H., Gbaguidi, F., Semde, R., Some, I., Quetin-Leclercq, J., Moudachirou, M., Piel, G., & Evrard, B. (2013). Effect of cyclodextrins on artemisinin stability and in vitro dissolution. International Journal of Biological and Chemical Sciences, 7 (1), 356-365.

Evrard, B., & Piel, G. (2012). Le double défi de la nanomédecine [Paper presentation]. Liège Créative, Liege, Belgium.

Piel, G., & Evrard, B. (29 November 2012). Le double défi de la nanomédecine [Paper presentation]. Liègre Créative.

Lechanteur, A., Evrard, B., Delvenne, P., RONCARATI, P., Hubert, P., & Piel, G. (November 2012). Development and optimization of lipoplex vectors for an antisens therapeutic approach in the context of HPV induced lesions [Poster presentation]. Ecole doctorale en cancérologie expérimentale, liège, Belgium.

Frère, A., Kawalec, M., Collard, L., Matheus, N., Peixoto, P., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (22 October 2012). Characterization and transfection experiments of polyplexes targeting HDAC7 [Poster presentation]. NanoFar Autumn School, Angers, France.

Furst, T., Lechanteur, A., Evrard, B., Delvenne, P., Hubert, P., Piette, M., & Piel, G. (22 October 2012). Development of a topical formulation containing lipoplexes able to inhibit E6 and E7 genes for the treatment of cervix cancer caused by HPV16 and HPV18 [Poster presentation]. NanoFar 1st Autumn School, Angers, France.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Hubert, P., & Piel, G. (22 October 2012). Development of a topical formulation containing lipoplexes able to inhibit E6 and E7 genes for the treatment of cervix cancer caused by HPV16 and HPV18 [Poster presentation]. NanoFar Automn School, Angers, France.

Krier, F., mantanus, J., Ziemons, E., Hubert, P., & Evrard, B. (16 October 2012). Comparison of in-line active content determination of polymeric implant by near infrared spectroscopy and Raman spectroscopy [Poster presentation]. Congrés annuel de l'AAPS2012.

Mehuys, E., Paemeleire, K., Van Hees, T., Van Bortel, L., Van Tongelen, I., Philippe, G., Prévôt, M.-L., Evrard, B., Piette, M., De Bolle, L., Remon, J., & Boussery, K. (September 2012). Zelfbehandeling van frequente hoofdpijn : een Belgische apotheekstudie [Paper presentation]. Second Belgian Pharmaceutical Care Symposium : Quality of care - Care for quality, Bruxelles, Belgium.

Donnez, J., Van Langendonkt, A., Defrère, S., Foidart, J.-M., Jérôme, C., Evrard, B., Riva, R., Krier, F., & Mestdagt, M. (19 July 2012). Implant comprising a core and a tube encasing the core.

Donnez, J., Van Langendonkt, A., Defrère, S., Foidart, J.-M., Jérôme, C., Evrard, B., Riva, R., Krier, F., & Mestdagt, M. (18 July 2012). Implant comprising a core and a tube encasing the core.

Mehuys, E., Paemeleire, K., Van Hees, T., Christiaens, T., Van Bortel, L., Van Tongelen, I., Philippe, G., Prévôt, M.-L., Evrard, B., Piette, M., De Bolle, L., Remon, J.-P., & Boussery, K. (June 2012). Automédication des céphalées fréquentes : étude dans les officines belges. Journal de Pharmacie de Belgique, 2, 4-10.

Ziemons, E., Mantanus, J., Rozet, E., Lebrun, P., Klinkerberg, R., Streel, B., Evrard, B., & Hubert, P. (March 2012). AN INNOVATIVE APPROACH TO SELECT THE PREDICTION MODEL IN THE DEVELOPMENT OF NIR SPECTROSCOPIC METHODS [Poster presentation]. AGROSTAT 2012, Paris, France.

Lebrun, P., Krier, F., Mantanus, J., Grohganz, H., Yang, M., Rozet, E., Boulanger, B., Evrard, B., Rantanen, J., & Hubert, P. (2012). Design space approach in the optimization of the spray-drying process. European Journal of Pharmaceutics and Biopharmaceutics, 80 (1), 226-234. doi:10.1016/j.ejpb.2011.09.014

Reschner, A., Shim, Y. H., Dubois, P., Evrard, B., DELVENNE, P., Marcelis, L., Moucheron, C., Kirsch Demmesmacher, A., Defrancq, E., Raes, M., Collard, L., & Piel, G. (2012). EVALUATION OF A NEW BIOCOMPATIBLE POLY(N-(MORPHOLINO ETHYL METHACRYLATE)-BASED COPOLYMER FOR THE DELIVERY OF Ruthenium oligonucleotides, targeting HPV16 E6 oncogene [Poster presentation]. GTRV, Paris, France.

Rocks, N., Bekaert, S., Coia, I., Paulissen, G., Guéders, M., Evrard, B., VAN HEUGEN, J.-C., CHIAP, P., Foidart, J.-M., Noël, A., & Cataldo, D. (2012). Curcumin-cyclodextrin complexes potentiate gemcitabine effects in an orthotopic mouse model of lung cancer. British Journal of Cancer, 107 (7), 1083-92. doi:10.1038/bjc.2012.379

Zime Diawara, H., Dive, G., Piel, G., Moudachirou, M., Quetin-Leclercq, J., Frederich, M., & Evrard, B. (2012). UNDERSTANDING THE INTERACTIONS BETWEEN ARTEMISININ AND CYCLODEXTRINS: SPECTROSCOPIC STUDIES AND MOLECULAR MODELING. Journal of Inclusion Phenomena and Molecular Recognition in Chemistry, 74 (1), 305-315. doi:10.1007/s10847-012-0117-9

Ducat, E., Deprez, J., Noël, A., Evrard, B., Peulen, O., & Piel, G. (06 December 2011). NUCLEAR DELIVERY OF A THERAPEUTIC PEPTIDE BY LONG CIRCULATING pH-SENSITIVE LIPOSOMES: BENEFITS OVER CLASSICAL VESICLES [Poster presentation]. XXVIth Scientific GTRV meeting, Bruxelles, Belgium.

Krier, F., Mantanus, J., Ziemons, E., & Evrard, B. (October 2011). In-line active content determination of polymeric implant by near infrared spectroscopy [Poster presentation]. AAPS Annual Meeting and Exposition, Washington, United States.

Mantanus, J., Rozet, E., Van Butsele, K., De Bleye, C., Ceccato, A., Evrard, B., Hubert, P., & Ziemons, E. (October 2011). Silicone-based drug reservoirs manufacturing process - Critical quality attributes evaluation using NIR and Raman spectroscopy [Poster presentation]. AAPS Annual Meeting and Exposition, Washington, United States.

De Bleye, C., Mantanus, J., Rozet, E., Van Butsele, K., Marini Djang'Eing'A, R., Ceccato, A., Evrard, B., Hubert, P., & Ziemons, E. (September 2011). BUILDING THE QUALITY INTO THE POLYMERIC SOLID DOSAGE FORM MANUFACTURING LINE - CRITICAL QUALITY ATTRIBUTES EVALUATION WITH NIR AND RAMAN PAT TOOLS [Poster presentation]. Recent Development in Pharmaceutical Analysis (RDPA), Pavia, Italy.

Alexandre, M., Zalfen, A., Riva, R., Nizet, D., Evrard, B., & Jérôme, C. (01 August 2011). Controlled release of drugs from multi-component biomaterials: drug release and mechanical properties studies [Paper presentation]. 38th Annual Meeting and Exposition of the Controlled Release Society, National Harbor, United States - Maryland.

Gillet, A., Lecomte, F., Hubert, P., Compère, P., Evrard, B., & Piel, G. (14 June 2011). Topical application of liposomes: parameters influencing their effectiveness [Poster presentation]. PharmSciFair, Prague, Czechia.

Gillet, A., Compère, P., Lecomte, F., Hubert, P., Ducat, E., Evrard, B., & Piel, G. (June 2011). Liposome surface charge influence on skin penetration behaviour. International Journal of Pharmaceutics, 411 (1-2), 223-231. doi:10.1016/j.ijpharm.2011.03.049

Ziemons, E., Mantanus, J., Rozet, E., Lebrun, P., Krier, F., Evrard, B., & Hubert, P. (June 2011). La spectroscopie vibrationnelle, outil indispensable pour l'industrie pharmaceutique ?

Jost, M., Frankenne, F., Maillard, C., Hubert, P., Herman, L., Delvenne, P., Piette, M., Coia, I., Evrard, B., Lecomte, F., Hubert, P., Englert, Y., Bossens, M., van Pachterbeke, C., GOFFIN, F., Doyen, J., Kridelka, F., Snoeck, R., & FOIDART, J.-M. (20 May 2011). From the Clinics to the Bench and back to the Clinics: design of a medical treatment for Cervical Intraepithelial Neoplasia (CIN) [Paper presentation]. GIGA-Cancer Day, Liège, Belgium.

Mantanus, J., Rozet, E., Lebrun, P., Evrard, B., Hubert, P., & Ziemons, E. (19 May 2011). Une solution analytique verte pour le PAT: la spectroscopie proche infrarouge [Paper presentation]. Chimie analytique verte: chromatographie en phase supercritique, liquides ioniques, haute température et miniaturisation, Paris, France.

Gillet, A., Lecomte, F., Hubert, P., Compère, P., Evrard, B., & Piel, G. (12 May 2011). Parameters influencing the skin penetration effectiveness of liposomes [Paper presentation]. 15th Forum of Pharmaceutical Sciences, Spa, Belgium.

Gillet, A., Lecomte, F., Hubert, P., Compère, P., Evrard, B., & Piel, G. (28 March 2011). Evaluation of parameters affecting skin penetration behaviour of liposomes [Poster presentation]. Skin Forum 12th Annual Meeting, Frankfurt, Germany.

Ducat, E., Deprez, J., Peulen, O., Evrard, B., & Piel, G. (25 March 2011). Peptide-loaded pH-sensitive Liposomes: effective penetration of Print3G in the nucleus of cancer cells [Paper presentation]. BIT's 4th annual protein and peptide conference, Pékin, China.

Berton, A., Piel, G., & Evrard, B. (2011). Powdered lipid nano and microparticles : production and applications. Recent Patents on Drug Delivery and Formulation, 5 (3), 188-200. doi:10.2174/187221111797200588

Defrère, S., Mestdagt, M., Riva, R., Krier, F., Van Langendonckt, A., Drion, P., Jérôme, C., Evrard, B., Dehoux, P., Foidart, J.-M., & Donnez, J. (2011). In vivo biocompatibility of three potential intraperitoneal implants. Macromolecular Bioscience, 11 (10), 1335-45. doi:10.1002/mabi.201100077

Ducat, E., Deprez, J., Gillet, A., Noël, A., Evrard, B., Peulen, O.* , & Piel, G.*. (2011). Nuclear delivery of a therapeutic peptide by long circulating pH-sensitive liposomes: Benefits over classical vesicles. International Journal of Pharmaceutics. doi:10.1016/j.ijpharm.2011.08.034
* These authors have contributed equally to this work.

Ducat, E., Evrard, B., Peulen, O., & Piel, G. (2011). Cellular uptake of liposomes monitored by confocal microscopy and flow cytometry. Journal of Drug Delivery Science and Technology, 21 (6), 469-477. doi:10.1016/S1773-2247(11)50076-0

Gillet, A., Evrard, B., & Piel, G. (January 2011). Liposomes and parameters affecting their skin penetration behaviour. Journal of Drug Delivery Science and Technology, 21, 35-42. doi:10.1016/S1773-2247(11)50004-8

Gillet, A., Lecomte, F., Hubert, P., Ducat, E., Evrard, B., & Piel, G. (2011). Skin penetration behaviour of liposomes as a function of their composition. European Journal of Pharmaceutics and Biopharmaceutics, 79, 43-53. doi:10.1016/j.ejpb.2011.01.011

Krier, F., Brion, M., Debrus, B., Lebrun, P., Driesen, A., Ziemons, E., Evrard, B., & Hubert, P. (2011). Optimisation and validation of a fast HPLC method for the quantification of sulindac and its related impurities. Journal of Pharmaceutical and Biomedical Analysis, 54, 694-700. doi:10.1016/j.jpba.2010.10.022

Mantanus, J., Rozet, E., Van Butsele, K., De Bleye, C., Ceccato, A., Evrard, B., Hubert, P., & Ziemons, E. (2011). Near infrared and Raman spectroscopy as Process Analytical Technology tools for the manufacturing of silicone-based drug reservoirs. Analytica Chimica Acta, 699, 96-106. doi:10.1016/j.aca.2011.05.006

ZIME DIAWARA, H., GBAGUIDI, F., Evrard, B., Quetin-Leclercq, J., MOUDACHIROU, M., Debrus, B., Hubert, P., & Rozet, E. (2011). Validation, transfer and measurement uncertainty estimation of an HPLC-UV method for the quantification of artemisinin in hydro alcoholic extracts of Artemisia annua L. Journal of Pharmaceutical and Biomedical Analysis, 56, 7-15. doi:10.1016/j.jpba.2011.04.012

Ziemons, E., Mantanus, J., Rozet, E., Lebrun, P., Klinkenberg, R., Streel, B., Moonen, F., Evrard, B., & Hubert, P. (08 December 2010). Vibrational spectroscopy in pharmaceutical industry: From development of the most appropriate predictive model to routine implementation [Poster presentation]. BioWin Day 2010, Louvain-la-Neuve, Belgium.

Ziemons, E., Mantanus, J., Rozet, E., Lebrun, P., Klinkenberg, R., Streel, B., Evrard, B., Moonen, F., & Hubert, P. (02 December 2010). Use of tolerance intervals in the development of near infrared spectroscopic methods: An innovative way to select the most appropriate calibration model [Poster presentation]. Chimiométrie 2010, Paris, France.

Ducat, E., Deprez, J., Peulen, O., Evrard, B., & Piel, G. (December 2010). Cellular uptake of long-circulating pH-sensitive liposomes: evaluation of the liposome and its encapsulated material penetration in cancer cells. Drug Discovery Today, 15 (23-24), 1079-1114. doi:10.1016/j.drudis.2010.09.362

Krier, F., Brion, M., Debrus, B., Lebrun, P., Driesen, A., Ziemons, E., Evrard, B., & Hubert, P. (15 November 2010). Optimisation and validation of a fast HPLC method for the quantification of sulindac and its related impurities [Poster presentation]. The FIP Pharmaceutical Sciences World Congress 2010 in association with the AAPS Annual Meeting & Exposition, new orléans, United States.

Mantanus, J., Ziemons, E., Streel, B., Klinkenberg, R., Evrard, B., Rantanen, J., & Hubert, P. (15 November 2010). NIR monitoring of solid and liquid forms manufacturing – Development and validation of in-line quantitative methods [Poster presentation]. FIP Pharmaceutical Sciences 2010 world congress, New Orleans, United States.

Mantanus, J., Lebrun, P., Rozet, E., Evrard, B., Hubert, P., & Ziemons, E. (14 October 2010). La spectroscopie proche infrarouge et Raman: Nouvelles armes vertes dans le contrôle de la qualité du médicament [Poster presentation]. Journée Scientifique Annuelle de la Société Royale de Chimie: Chimie Verte, Gembloux, Belgium.

Ducat, E., Deprez, J., Peulen, O., Evrard, B., & Piel, G. (October 2010). PEPTIDE-LOADED LIPOSOMES AGAINST BREAST CANCER: EFFECTIVE PENETRATION IN CELLS OF LONG CIRCULATING pH-SENSITIVE VESICLES [Poster presentation]. 2nd conference on "Innovation in Drug Delivery: From Preformulation to Development through Innovative Evaluation Process", Aix-en-Provence, France.

Gillet, A., Lecomte, F., Hubert, P., Evrard, B., & Piel, G. (October 2010). Interest of vesicular systems in dermal drug delivery [Poster presentation]. 2nd Innovation in Drug Delivery, Aix-en-Provence, France.

Piel, G., Collard, L., Evrard, B., Delvenne, P., Dubois, P., & Reschner, A. (October 2010). POLYPLEXES TARGETING E6: OPTIMIZATION OF THE FORMULATIONS IN TERMS OF TRANSFECTION, TOXICITY AND EFFICIENCY [Poster presentation]. 2nd Conference Innovation in Drug Delivery: From Preformulation to development through Innovative Evaluation Process, Aix en Provence, France.

Mantanus, J., Ziemons, E., Van Butsele, K., Evrard, B., Ceccato, A., & Hubert, P. (24 September 2010). NIR AND RAMAN SPECTROSCOPY AS PAT TOOLS FOR THE MANUFACTURING OF SILICONE-BASED DRUG RESERVOIRS [Paper presentation]. Drug Analysis 2010, Anvers, Belgium.

Philippe, G., Angenot, L., Evrard, B., Giet, D., Piette, M., Prévôt, M.-L., & BOURGUIGNON, J.-P. (18 September 2010). L'ECOS ou 'comment les pharmaciens d'officine évaluent l'aptitude des étudiants à prodiguer des soins pharmaceutiques de qualité' [Paper presentation]. First Pharmaceutical Care Symposium, Bruxelles, Belgium.

Krier, F., Brion, M., Debrus, B., Lebrun, P., Driesen, A., Evrard, B., & Hubert, P. (September 2010). Optimisation and validation of a fast HPLC method for the quantitation of sulindac and its impurities [Poster presentation]. Drug Analysis 2010, Anvers (Antwerp), Belgium.

Ziemons, E., Mantanus, J., Rozet, E., Lebrun, P., Klinkenberg, R., Streel, B., Evrard, B., & Hubert, P. (September 2010). An innovative approach to select the prediction model in the development of NIR spectroscopy methods [Poster presentation]. Drug Analysis, Antwerpen, Belgium.

Gillet, A., Lecomte, F., Hubert, P., Evrard, B., & Piel, G. (06 July 2010). Penetration mechanism of classical and deformable liposomes through pig ear skin [Poster presentation]. Skin Forum 11th Annual Meeting, Edinburgh, United Kingdom.

Ducat, E., Brion, M., Lecomte, F., Evrard, B., & Piel, G. (June 2010). The experimental design as practical approach to develop and optimize a formulation of peptide-loaded liposomes. AAPS PharmSci, 11 (2), 966-975. doi:10.1208/s12249-010-9463-3

Mantanus, J., Ziemons, E., Evrard, B., Van Butsele, K., Ceccato, A., & Hubert, P. (05 May 2010). NIR Real-time monitoring of a silicone-based drug reservoir crosslinking process [Poster presentation]. 4th Pan European Pat Science conference, Kuopio, Finland.

Mantanus, J., Ziemons, E., Streel, B., Klinkenberg, R., Evrard, B., Rantanen, J., & Hubert, P. (05 May 2010). NIR as a PAT tool for solid and liquid forms manufacturing - Development and validation of in-line quantitative methods [Poster presentation]. 4th Pan European Pat Science conference, Kuopio, Finland.

Gillet, A., Lecomte, F., Rozet, E., Hubert, P., Evrard, B., & Piel, G. (09 April 2010). Suggested mechanism of action of classical and deformable liposomes through pig ear skin [Paper presentation]. Perspectives in Percutaneous Penetration 2010 12th International Conference, La Grande Motte, France.

Gillet, A., Lecomte, F., Rozet, E., Hubert, P., Evrard, B., & Piel, G. (29 March 2010). Classical and deformable liposomes: possible mechanism of penetration through pig ear skin [Poster presentation]. 8th International Conference and Workshop on Biological Barriers, Saarbrücken, Germany.

Castagne, D., Dive, G., Evrard, B., Frederich, M., & Piel, G. (2010). Spectroscopic studies and molecular modeling for understanding the interactions between cholesterol and cyclodextrins. Journal of Pharmacy and Pharmaceutical Sciences, 13 (2), 362-377. doi:10.18433/j3bs34

Castagne, D., Evrard, B., Nusgens, B., & Piel, G. (2010). Effect of β-cyclodextrin and its derivatives on caveolae disruption, relationships with their cholesterol extraction capacities. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 67, 369-376. doi:10.1007/s10847-009-9718-3

Dehousse, V., Garbacki, N., Colige, A., & Evrard, B. (2010). Development of pH–responsive nanocarriers using trimethylchitosans and methacrylic acid copolymer for siRNA delivery. Biomaterials, 31, 1839-1849. doi:10.1016/j.biomaterials.2009.11.028

Dehousse, V., Garbacki, N., Jaspart, S., Castagne, D., Piel, G., Colige, A., & Evrard, B. (2010). Comparison of chitosan/siRNA and trimethylchitosan/siRNA complexes behaviour in vitro. International Journal of Biological Macromolecules, 46, 342-349. doi:10.1016/j.ijbiomac.2010.01.010

Ducat, E., Deprez, J., Neuville, N., Peulen, O., Evrard, B., & Piel, G. (2010). Long-circulating liposomes: comparison between pH-sensitive and standard vesicles in terms of cellular uptake [Paper presentation]. 7th world meeting on pharmaceutics, biopharmaceutics and pharmaceutical technology, La Valette, Malta.

Evrard, B. (2010). Technologie Pharmaceutique et Biopharmacie. (ULiège - Université de Liège, PHAR0343-1).

Forbes, B., Cao Minh, Q. A., Evrard, B., Kumar, A., & Dailey, L. (2010). In vitro safety assessment of inhaled products using respiratory epithelial cells [Poster presentation]. Respiratory Drug Delivery Conference 2010, Orlando, Flo, United States.

Gillet, A., Lecomte, F., Rozet, E., Hubert, P., Evrard, B., & Piel, G. (2010). Suggested mechanism of action of classical and deformable liposomes through pig ear skin. Journal of Pharmacy and Pharmacology, 62 (6), 788-807.

Hubert, P., Doyen, J., Capelle, X., Arafa, M., Renoux, V., Bisig, B., Seidel, L., Evrard, B., Bousarghin, L., Gerday, C., Boniver, J., Foidart, J.-M., Delvenne, P., & Jacobs, N. (2010). Local applications of GM-CSF induce the recruitment of immune cells in cervical low-grade squamous intraepithelial lesions. American Journal of Reproductive Immunology, 64 (2), 126-136. doi:10.1111/j.1600-0897.2010.00834.x

Mantanus, J., Ziemons, E., Lebrun, P., Rozet, E., Klinkenberg, R., Streel, B., Evrard, B., & Hubert, P. (2010). Active content determination of non-coated pharmaceutical pellets by near infrared spectroscopy: Method development, validation and reliability evaluation. Talanta, 80, 1750-1757. doi:10.1016/j.talanta.2009.10.019

Mantanus, J., Ziemons, E., Rozet, E., Streel, B., Klinkenberg, R., Evrard, B., Rantanen, J., & Hubert, P. (2010). Building the quality into pellet manufacturing environment - feasibility study and validation of an in-line quantitative near infrared (NIR) method. Talanta, 83, 305-311. doi:10.1016/j.talanta.2010.09.009

Ziemons, E., Mantanus, J., Lebrun, P., Rozet, E., Evrard, B., & Hubert, P. (2010). Acetaminophen determination in low-dose pharmaceutical syrup by NIR spectroscopy. Journal of Pharmaceutical and Biomedical Analysis, 53, 510-516. doi:10.1016/j.jpba.2010.06.003

Ziemons, E., Sacre, P.-Y., Evrard, B., & Hubert, P. (2010). Process Analytical Technology (PAT) - Technologie de contrôle des Procédés. (ULiège - Université de Liège, PHIN2022-1 Production industrielle des formes pharmaceutiques).

Ouédraogo, M., Semdé, R., Somé, I. T., Ouédraogo, M., Ouédraogo, R., Henschel, V., Evrard, B., Dubois, J., Amighi, K., & Guissou, I. P. (December 2009). Development of an in vitro endotoxin test for monoolein-water liquid crystalline gel for use as an implant. Tropical Journal of Pharmaceutical Research, 8 (6), 501-508.

Brion, M., Jaspart, S., Perrone, L., Piel, G., & Evrard, B. (November 2009). The supercritical micronization of solid dispersions by Particles from Gas Saturated Solutions using experimental design. Journal of Supercritical Fluids, 51 (1), 50-56. doi:10.1016/j.supflu.2009.06.021

Gillet, A., Grammenos, A., Compère, P., Evrard, B., & Piel, G. (01 October 2009). Development of a new topical system: Drug-in-cyclodextrin-in-deformable liposome. International Journal of Pharmaceutics, 380 (1-2), 174-180. doi:10.1016/j.ijpharm.2009.06.027

Mantanus, J., Ziemons, E., Streel, B., Klinkenberg, R., Evrard, B., Hubert, P., & Rantanen, J. (September 2009). Production line real time near infrared (NIR) monitoring [Paper presentation]. 3rd Annual Pharmaceutical Solid State Research Cluster Symposium, Copenhagen, Denmark.

Mantanus, J., Ziemons, E., Streel, B., Klinkenberg, R., Evrard, B., Hubert, P., & Rantanen, J. (August 2009). Quantitative in-line monitoring of pharmaceutical pellets active content using near infrared spectroscopy [Poster presentation]. 3rd Annual Pharmaceutical Solid State Research Cluster Symposium, Copenhagen, Denmark.

Gillet, A., Lecomte, F., Rozet, E., Hubert, P., Evrard, B., & Piel, G. (09 June 2009). Betamethasone in cyclodextrin in deformable liposomes for dermal applications: ex vivo diffusion studies [Paper presentation]. PharmSciFair, Nice, France.

Gillet, A., Lecomte, F., Rozet, E., Hubert, P., Evrard, B., & Piel, G. (07 June 2009). Betamethasone in cyclodextrin in deformable liposomes for dermal applications: ex vivo diffusion studies [Poster presentation]. PharmSciFair, Nice, France.

Castagne, D., Frederich, M., Evrard, B., Nusgens, B., Dive, G., & Piel, G. (June 2009). Studies for understanding the interactions between biological membranes and cyclodextrins and their effects at the cell level [Poster presentation]. 2nd PharmSciFair, Nice, France.

Krier, F., Riva, R., Mestdagt, M., van langendonckt, A., Jérôme, C., Piel, G., & Evrard, B. (June 2009). Development of an intraperitoneal implant for abdomino-pelvic chronic diseases [Poster presentation]. 2nd Pharmaceutical Sciences Fair and Exhibition - PharmSciFair 2009, Nice, Belgium.

Krier, F., Riva, R., Mestdagt, M., van langendonckt, A., Jérôme, C., Piel, G., & Evrard, B. (June 2009). Development of an intraperitoneal implant for abdomino-pelvic chronic diseases [Poster presentation]. Pre-Satellite Young Scientists Meeting, nice, France.

Mantanus, J., Ziemons, E., Streel, B., Klinkenberg, R., Evrard, B., Hubert, P., & Rantanen, J. (June 2009). Interfacing near infrared (NIR) spectroscopy with production line - Role of sample movement and density [Poster presentation]. Premier European Platform for Advancing Pharmaceutical Sciences, Nice, France.

Gillet, A., Grammenos, A., Lecomte, F., Rozet, E., Hubert, P., Evrard, B., & Piel, G. (14 May 2009). Betamethasone in cyclodextrin in deformable liposomes for cutaneous applications: development and diffusion studies [Paper presentation]. Quatorzième Forum des Sciences Pharmaceutiques, Blankenberge, Belgium.

Coia, I., Evrard, B., & Piette, M. (01 April 2009). Preparations and characterisations of semi-solid formulations containing a hydrophilic drug for vaginal administration [Poster presentation]. Biomedica, Liège, Belgium.

Gillet, A., Lecomte, F., Rozet, E., Hubert, P., Evrard, B., & Piel, G. (01 April 2009). Betamethasone in cyclodextrin in deformable liposomes for topical applications: absorption studies using pig skin [Poster presentation]. Biomedica, Liège, Belgium.

Gillet, A., Grammenos, A., Evrard, B., & Piel, G. (09 March 2009). Development of a new cutaneous delivery system: drug in cyclodextrin in deformable liposomes [Poster presentation]. Skin and Formulation 3rd Symposium and Skin Forum 10th Annual Meeting, Versailles, France.

Gillet, A., Lecomte, F., Rozet, E., Hubert, P., Evrard, B., & Piel, G. (09 March 2009). development and validation of a SPE-LC-UV method for the determination of betamethasone in pig skin [Poster presentation]. Skin and Formulation 3rd Symposium and Skin Forum 10th Annual Meeting, Versailles, France.

Gillet, A., Grammenos, A., Evrard, B., & Piel, G. (03 February 2009). Mise au point de liposomes déformables contenant de la bétamethasone encapsulée sous forme de complexes dans des cyclodextrines dans le but d'une application dermatologique [Paper presentation]. Forum des Jeunes Chercheurs, Liège, Belgium.

Krier, F., Evrard, B., Piel, G., & Riva, R. (03 February 2009). Développement d'un implant intra-péritonéal contre l'endométriose [Paper presentation]. Forum des Jeunes Chercheurs du CIRM, Liège, Belgium.

Cataldo, D., Evrard, B., Foidart, J.-M., & Noël, A. (08 January 2009). USE OF CYCLODEXTRIN FOR TREATMENT AND PREVENTION OF BRONCHIAL INFLAMMATORY DISEASES.

Belhadj Salem, L., Bosquillon, C., Dailey, L. A., Delattre, L., Martin, G. P., Evrard, B., & Forbes, B. (2009). Sparing methylation of β-cyclodextrin mitigates cytotoxicity and permeability induction in respiratory epithelial cell layers in vitro. Journal of Controlled Release, 136, 110-116. doi:10.1016/j.jconrel.2009.01.019

Castagne, D., Fillet, M., Delattre, L., Evrard, B., Nusgens, B., & Piel, G. (2009). Study of the cholesterol extraction capacity of β-cyclodextrin and its derivatives, relationships with their effects on endothelial cell viability and on membrane models. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 63 (3-4), 225-231. doi:10.1007/s10847-008-9510-9

Cosijns, A, Nizet, D, Nikolakakis, I, Vervaet, C, De Beer, T, Siepmann, F, Siepmann, J, Evrard, B., & Remon, J-P. (2009). Porous pellets as drug delivery system. Drug Development and Industrial Pharmacy, 35 (6), 655-662. doi:10.1080/03639040802578103

Dehousse, V., Garbacki, N., Colige, A., & Evrard, B. (2009). Characterisation and evaluation of nanoparticles made of chitosan and timethylchitosan as siRNA carriers. In Proceedings of 2nd PharmSci Fair.

Ducat, E., Brion, M., Evrard, B., & Piel, G. (2009). FORMULATION OF PEPTIDE-LOADED LIPOSOMES FOR INTRAVENOUS DELIVERY: OPTIMIZATION OF THE ENCAPSULATION EFFICIENCY [Paper presentation]. 14th forum of pharmaceutical sciences, Blankenberge, Belgium.

Ducat, E., Brion, M., Evrard, B., & Piel, G. (2009). CHARACTERIZATION AND OPTIMIZATION OF PEPTIDE ENCAPSULATION IN PEGYLATED LIPOSOMES [Poster presentation]. Biomedica, Liège, Belgium.

Ducat, E., Brion, M., Evrard, B., & Piel, G. (2009). CHARACTERIZATION AND OPTIMIZATION OF PEPTIDE ENCAPSULATION IN PEGYLATED LIPOSOMES [Poster presentation]. Pharmscifair, Nice, France.

Ducat, E., Brion, M., Evrard, B., & Piel, G. (2009). CARACTERISATION ET OPTIMISATION DE L’ENCAPSULATION D’UN PEPTIDE ANTAGONISTE D’ONCOPROTEINE AU SEIN DE LIPOSOMES PEGYLES [Paper presentation]. Forum des jeunes chercheurs.

Mantanus, J., Ziemons, E., Lebrun, P., Rozet, E., Klinkenberg, R., Streel, B., Evrard, B., & Hubert, P. (2009). Moisture content determination of pharmaceutical pellets by near infrared spectroscopy: method development and validation. Analytica Chimica Acta, 642 (1-2), 186-92. doi:10.1016/j.aca.2008.12.031

Zime Diawara, H., Gbaguidi, F., Gbenou, J., Laleye, A., Semde, R., Some, I., Sinsin, B., Moudachirou, M., Quetin-Leclercq, J., & Evrard, B. (2009). Preliminary studies of development of oral pharmaceutical dosage forms contained extracts of Artemisia annua cultivated in Benin. In Proceedings of 2nd PharmSci Fair.

Noël, A., Herman, L., Hubert, P., Delvenne, P., Boniver, J., Evrard, B., Delattre, L., Frankenne, F., & Foidart, J.-M. (27 November 2008). MUCOADHESIVE PHARMACEUTICAL COMPOSITIONS COMPRISING CHEMOATTRACTANTS.

Gillet, A., Grammenos, A., Evrard, B., & Piel, G. (26 November 2008). Caractérisation et étude de diffusion in vitro de liposomes deformables contenant de la bétaméthasone encapsulée sous la forme de complexes dans des cyclodextrines [Poster presentation]. 11 émes Journées du Club Français des Cyclodextrines, Rouen, France.

Castagne, D., Frederich, M., Dive, G., Evrard, B., & Piel, G. (November 2008). Etude par modélisation moléculaire et spectroscopie RMN des interactions entre le cholestérol et les cyclodextrines afin de comprendre leurs effets sur les membranes cellulaires [Paper presentation]. 11èmes Journées du Club français des Cyclodextrines, Rouen, France.

Zalfen, A., Nizet, D., Jérôme, C., Jérôme, R., frankenne, F., Foidart, J.-M., Maquet, V., Lecomte, F., Hubert, P., & Evrard, B. (November 2008). Controlled release of drugs from multi-component biomaterials. Acta Biomaterialia, 4 (6), 1788-1796. doi:10.1016/j.actbio.2008.05.021

Gillet, A., Grammenos, A., Evrard, B., & Piel, G. (10 October 2008). Betamethasone in cyclodextrin in deformable liposomes, a new cutaneous delivery system: characterization and in vitro diffusion studies [Paper presentation]. European IP-Galenos Course- Skin barrier Function: Cutaneous absoprtion and environmental factors, Lyon, France.

Castagne, D., Blacher, S., Alvarez Gonzalez, M.-L., Berndt, S., Piette, M., Evrard, B., Nusgens, B., Noël, A., & Piel, G. (May 2008). Effect of b-cyclodextrin and its methylated derivatives on the ex-vivo rat aortic ring angiogenesis assay [Poster presentation]. XIIth BELACT Meeting, Namur, Belgium.

Maquet, V., Pagnoulle, C., Evrard, B., Jérôme, R., Foidart, J.-M., & Frankenne, F. (24 April 2008). Active Substance Delivery System Comprising A Hydrogel Matrix And Microcarriers.

Castagne, D., Fillet, M., Evrard, B., Nusgens, B., & Piel, G. (April 2008). Determination of the ideal cyclodextrin concentrations to study their effect in the lipid rafts by the use of cholesterol extraction and cell viability studies in endothelial cells [Poster presentation]. 6th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Barcelona, Spain.

Barillaro, V., Dive, G., Ziemons, E., Bertholet, P., Evrard, B., Delattre, L., & Piel, G. (10 February 2008). Theoretical and Experimental Vibrational Study of Miconazole and Its Dimers with Organic Acids: Application to the IR Characterization of Its Inclusion Complexes with Cyclodextrins. International Journal of Pharmaceutics, 350 (1-2), 155-165. doi:10.1016/j.ijpharm.2007.08.048

Barillaro, V., Dive, G., Bertholet, P., Evrard, B., Delattre, L., Frederich, M., Ziemons, E., & Piel, G. (22 January 2008). Theoretical and Experimental Investigations of Organic Acids/Cyclodextrin Complexes and Their Consequences Upon the Formation of Miconazole/Cyclodextrin/Acid Ternary Inclusion Complexes. International Journal of Pharmaceutics, 347 (1-2), 62-70. doi:10.1016/j.ijpharm.2007.06.030

Bertolla, C, Rolin, S, Evrard, B., Pochet, L, & Masereel, B. (2008). Synthesis and pharmacological evaluation of a new targeted drug carrier system: β-Cyclodextrin coupled to oxytocin. Bioorganic and Medicinal Chemistry Letters, 18, 1855-1858. doi:10.1016/j.bmcl.2008.02.017

Brion, M., Nizet, D., & Evrard, B. (2008). Optimization of a drug-cyclodextrin complexation reaction by a static supercritical carbon dioxide process [Poster presentation]. 6th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Barcelona, Spain.

Ducat, E., Evrard, B., & Piel, G. (2008). STUDY OF PEGYLATED LIPOSOMES CRYOPROTECTION IN TERMS OF RETENTION EFFICIENCY [Poster presentation]. 6th international workshop on drug delivery systems for nanomedecines, Liblice, Czechia.

Guéders, M., Bertholet, P., Perin, F., Rocks, N., Marée, R., Botta, V., Louis, R., Foidart, J.-M., Noël, A., Evrard, B., & Cataldo, D. (2008). A novel formulation of inhaled doxycycline reduces allergen-induced inflammation, hyperresponsiveness and remodeling by matrix metalloproteinases and cytokines modulation in a mouse model of asthma. Biochemical Pharmacology, 75 (2), 514-26. doi:10.1016/j.bcp.2007.09.012

Krier, F., Nizet, D., Riva, R., Mestdagt, M., Frankenne, F., Jérôme, C., Piel, G., & Evrard, B. (2008). DEVELOPMENT OF AN INTRAPERITONEAL IMPLANT FOR THE ENDOMETRIOSIS TREATMENT [Poster presentation]. 6th World Meeting on Pharmaceutics, biopharmaceutics and pharmaceutical technology, Barcelone, Spain.

Mantanus, J., Ziemons, E., Lebrun, P., Rozet, E., Klinkenberg, R., Streel, B., Evrard, B., & Hubert, P. (2008). Determination of moisture content in pharmaceutical pellets using near infrared spectroscopy: Method development and validation [Paper presentation]. PAT Workshop, Gent, Belgium.

Nizet, D., Jaspart, S., Brion, M., Lecomte, F., & Evrard, B. (2008). Use of supercritical fluids technology (PGSS) for the production of betametazone loaded solid lipid microparticles [Poster presentation]. 6th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Barcelona, Spain.

Ouédraogo, M, Da, C.S, Nacoulma, I.S, Kafando, H, Semde, R, Some, I.T, Ouédraogo, R, Guissou, I.P, Evrard, B., Henschel, V, Dubois, J, & Amighi, K. (2008). Preliminary Clinical Assessment of a Gentamicin-Loaded Monoolein Gel Intended to Treat Chronic Osteomyelitis. Trends in Medical Research, 3 (2), 82-89. doi:10.3923/tmr.2008.82.89

Ouédraogo, M, Nacoulma, E.C, Semdé, R, Somé, I.T, Guissou, I.P, Henschel, V, Evrard, B., Amighi, K, & Dubois, J. (2008). In vitro Biocompatibility and Genotoxicity Assessment of a Gentamicin-Loaded Monoolein Gel Intended to Treat of Chronic Osteomyelitis. Journal of Pharmacology and Toxicology, 3 (5).

Ouédraogo, M, Sanou, M, Ramdé, N, Goumbri, O, Somé, I.T, Semdé, R, Ouédraogo, R, Guissou, I.P, Henschel, V, Evrard, B., Amighi, K, & Dubois, J. (2008). In vivo Biocompatibility and Toxicity Assessment of a Gentamicin-Loaded Monoolein Gel Intended to Treat Chronic Osteomyelitis. Journal of Pharmacology and Toxicology, 3 (5), 386-393.

Ouédraogo, M, Semdé, R, Somé, I.T, Traoré Ouédraogo, R, Guissou, I.P, Henschel, V, Dubois, J, Amighi, K, & Evrard, B. (2008). Monoolein-water liquid crystalline gels of gentamicin as bioresorbable implants for the local treatment of chronic osteomyelitis: in vitro characterization. Drug Development and Industrial Pharmacy, 34, 753-760. doi:10.1080/03639040801926287

Volvert, M.-L., Seyen, S., Piette, M., Evrard, B., Gangolf, M., Plumier, J.-C., & Bettendorff, L. (2008). Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives. BMC Pharmacology, 8, 10. doi:10.1186/1471-2210-8-10

Castagne, D., Fillet, M., Delattre, L., Evrard, B., Nusgens, B., & Piel, G. (November 2007). Interaction de la b-cyclodextrine et de ses dérivés avec des cellules endothéliales: dosage du cholestérol résiduel [Paper presentation]. 10èmes Journées du Club français des Cyclodextrines, Lens, France.

Bodson, C., Rozet, E., Ziemons, E., Evrard, B., Hubert, P., & Delattre, L. (18 October 2007). Validation of manufacturing process of Diltiazem HCl tablets by NIR spectrophotometry (NIRS). Journal of Pharmaceutical and Biomedical Analysis, 45 (2), 356-361. doi:10.1016/j.jpba.2007.05.015

Castagne, D., Delattre, L., Evrard, B., Fillet, M., Nusgens, B., & Piel, G. (October 2007). Cell membrane destructuration using cyclodextrins: effect on cholesterol content of endothelial cells [Paper presentation]. XIIIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Dehousse, V., Piel, G., Delattre, L., & Evrard, B. (October 2007). Characterization of siRNA lipoplexes in terms of size and zeta potential data [Poster presentation]. 1st conference on "innovation in drug delivery: from biomaterials to devices", Naples, Italy.

Piel, G., Ducat, E., Grammenos, A., Evrard, B., & Delattre, L. (October 2007). Encapsulation of betamethasone-HP-gCD complex in deformable liposomes [Poster presentation]. 1st conference on "innovation in drug delivery: from biomaterials to devices", Naples, Italy.

Krell, H.-W., Cataldo, D., Delattre, L., Evrard, B., & Foidart, J.-M. (27 September 2007). USE OF A TRIOXOPYRIMIDINE FOR THE TREATMENT AND PREVENTION OF BRONCHIAL INFLAMMATORY DISEASES.

Evrard, B., Bartsch, P., Endele, R., Foidart, J.-M., Krell, H.-W., Cataldo, D., & Zimmermans, G. (16 August 2007). CYCLODEXTRIN INCLUSIONS COMPLEXES OF PYRIMIDINE-2,4,6-TRIONES.

Herman, L., Hubert, P., Caberg, J.-H., Evrard, B., Kedzia, W., Boniver, J., & Delvenne, P. (July 2007). MIP3 alpha stimulates the migration of Langerhans cells in models of human papillomavirus (HPV)-associated (pre)neoplastic epithelium. Cancer Immunology, Immunotherapy, 56 (7), 1087-1096. doi:10.1007/s00262-006-0255-2

Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (29 June 2007). Study of the relationship between lipid binding properties of cyclodextrins and their effect on the integrity of liposomes. International Journal of Pharmaceutics, 338 (1-2), 35-42. doi:10.1016/j.ijpharm.2007.01.015

Cataldo, D., Evrard, B., Foidart, J.-M., & Noël, A. (27 June 2007). USE OF CYCLODEXTRIN FOR TREATMENT AND PREVENTION OF BRONCHIAL INFLAMMATORY DISEASES.

Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (April 2007). Study of the interaction between cyclodextrins and liposome membranes: effect on the permeability of liposomes. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 57 (1-4), 309-311. doi:10.1007/s10847-006-9178-y

Barillaro, V., Dive, G., Bertholet, P., Evrard, B., Delattre, L., Ziemons, E., & Piel, G. (2007). Theoretical and experimental investigations on miconazole/cyclodextrin/acid complexes: Molecular modeling studies. International Journal of Pharmaceutics, 342 (1-2), 152-160. doi:10.1016/j.ijpharm.2007.05.003

Belhadj Salem, L., Bosquillon, C., Delattre, L., Martin, G., Evrard, B., & Forbes, B. (2007). Kleptose Crysmeb is a biocompatiblecyclodextrin solubiliser for pulmonary delivery of Ro 28-2653, a new synthetix matrix metalloproteinase inhibitor [Poster presentation]. Pharmaceutical Sciences World Congress.

Belhadj-Salem, L., Bosquillon, C., Delattre, L., Martin, G., Forbes, B., & Evrard, B. (2007). Effect of cyclodextrin derivatives on bronchial epithelial cell layer permeability [Poster presentation]. Innovation in drug delivery: from biomaterials to devices, Naples, Italy.

Brion, M., Nizet, D., Piel, G., Delattre, L., & Evrard, B. (2007). Optimization of drug-cyclodextrin complexation reaction by a static supercritical carbon dioxide method [Paper presentation]. XIIIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Brion, M., Nizet, D., Piel, G., Delattre, L., & Evrard, B. (2007). Optimisation de la réaction de complexation entre une cyclodextrine et un composé pharmaceutique par utilisation du CO2 supercritque [Paper presentation]. 10èmes Journées du Club français des Cyclodextrines, Lens, France.

Dehousse, V., Piel, G., Delattre, L., & Evrard, B. (2007). Studies on the structure of cationic liposomes/siRNA complexes by zeta potential and size measurement [Paper presentation]. XIIIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Evrard, B., Bertholet, P., Guéders, M., Piette, M., Piel, G., Cataldo, D., & Delattre, L. (2007). Contribution of cyclodextrins in the developement of different pharmaceutical formulations of a nex matrix metalloproteinase inhibitor. Journal of Inclusion Phenomena and Molecular Recognition in Chemistry, 57 (1-4), 303-308. doi:10.1007/s10847-006-9177-z

Hubert, P., Doyen, J., Chapelle, X., Evrard, B., Gerday, C., Boniver, J., Foidart, J.-M., & Jacobs, N. (2007). Phase I/IIclinical trial of local GM-CSF application in patients with cervical HPV-associated low grade squamous intraepithelial lesions [Paper presentation]. 24th International Papillomavirus Conference and Clinical Workshops, Bejing, China.

Jaspart, S., Bertholet, P., Piel, G., Dogné, J.-M., Delattre, L., & Evrard, B. (January 2007). Solid lipid microparticles as a sustained release system for pulmonary drug delivery. European Journal of Pharmaceutics and Biopharmaceutics, 65 (1), 47-56. doi:10.1016/j.ejpb.2006.07.006

Jaspart, S., Delattre, L., & Evrard, B. (2007). Formulation and in vitro evaluation of inhalable dry powders containing solid lipid nanoparticles [Poster presentation]. Innovation in drug delivery: from biomaterials to devices, Naples, Italy.

Krier, F., Nizet, D., Riva, R., colombo, M., Frankenne, F., Jérôme, C., Piel, G., Delattre, L., & Evrard, B. (2007). DEVELOPMENT OF AN INTRAPERITONEAL IMPLANT FOR THE ENDOMETRIOSIS TREATMENT [Paper presentation]. XIIIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Nizet, D., Jaspart, S., Brion, M., Piel, G., Delattre, L., & Evrard, B. (2007). Supercritical fluid technology to produce solid lipid microparticles [Paper presentation]. XIIIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Nizet, D., Zalfen, A., Collard, L., Krier, F., Jérôme, C., Frankenne, F., Delattre, L., & Evrard, B. (2007). Development of an original intra-uterine implant allowed specific release kinetics of several drugs [Poster presentation]. Innovation in drug delivery: from biomaterials to devices, Naples, Italy.

Nizet, D., Zalfen, A., Collard, L., Krier, F., Jérôme, C., Frankenne, F., Maquet, V., Delattre, L., & Evrard, B. (2007). Controlled release of drugs from an original multi-component device [Poster presentation]. Biomedica 2007, aachen, Germany.

Nizet, D., Zalfen, A., Jérôme, C., Frankenne, F., Delattre, L., & Evrard, B. (2007). Controlled release of drug from multicomponent device [Poster presentation]. Pharmaceutical Sciences World Congress, Amsterdam, Netherlands.

Hubert, P., Evrard, B., Delattre, L., Boniver, J., Delvenne, P., Noël, A., Frankenne, F., & Foidart, J.-M. (12 December 2006). Mucoadhesive composition comprising polyacrylate and chemoattractant.

Piel, G., Coia, I., Uhoda, E., Pierard, G., Evrard, B., & Delattre, L. (October 2006). Assessment of betamethasone-in-cyclodextrin-in-liposome induced skin blanching response [Poster presentation]. Skin and Formulation, 2nd Symposium, Versailles, France.

Herman, L., Hubert, P., Delvenne, P., Boniver, J., Evrard, B., Delattre, L., Frankenne, F., Noël, A., & Foidart, J.-M. (28 June 2006). MUCOADHESIVE PHARMACEUTICAL COMPOSITIONS COMPRISING CHEMOATTRACTANTS.

Piette, M., Evrard, B., Frankenne, F., Chiap, P., Bertholet, P., Castagne, D., Foidart, J.-M., Delattre, L., & Piel, G. (June 2006). Pharmacokinetic study of a new synthetic MMP inhibitor (Ro 28-2653) after IV and oral administration of cyclodextrin solutions. European Journal of Pharmaceutical Sciences, 28 (3), 189-195. doi:10.1016/j.ejps.2006.01.011

Hubert, C., Rozet, E., Boulanger, B., Dewé, W., Breuer, A., Collard, L., Evrard, B., & Hubert, P. (May 2006). Validation of a LC method for the determination of levonorgestrel released from a polymeric matrix. A two days protocol [Poster presentation]. Drug Analysis 2006, Namur, Belgium.

Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (07 April 2006). Betamethasone-in-cyclodextrin-in-liposome: The effect of cyclodextrins on encapsulation efficiency and release kinetics. International Journal of Pharmaceutics, 312 (1-2), 75-82. doi:10.1016/j.ijpharm.2005.12.044

Barillaro, V., Van Hees, T., Piel, G., Evrard, B., & Delattre, L. (2006). Application of supercritical carbon dioxide to the preparation of inclusion complexes into cyclodextrins [Paper presentation]. 13th International Pharmaceutical Technology Symposium, Antalya, Turkey.

Bosquillon, C, Belhadj Salem, L, Hernandez, E, Martin, G.P, Delattre, L., Evrard, B., & Forbes, B. (2006). Effect of ß-Cyclodextrin Derivatives on Bronchial Epithelial Cell Layer Permeability. Delivery to the lung, 17, 90-93.

Kirschvink, N, Leemans, J., Delvaux, F., Snaps, F., Jaspart, S., Evrard, B., Delattre, L., Cambier, C., Clercx, C., & Gustin, P. (2006). Inhaled fluticasone reduces bronchial responsiveness and airway inflammation in cats with mild chronic bronchitis. Journal of Feline Medicine and Surgery, 8 (1), 45-54. doi:10.1016/j.jfms.2005.07.001

Patel, J., Belhadj Salem, Martin, G. P., Delattre, L., Evrard, B., Forbes, B., & Bosquillon, C. (2006). Use of the MTT assay to evaluate the biocompatibility of beta-cyclodextrin derivatives with respiratory epithelial cells. Journal of Pharmacy and Pharmacology, 58 (58), 64-65.

Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (2006). Study of the interaction between cyclodextrins and liposomes membranes: effect on the permeability of liposomes [Paper presentation]. XIII th International Cyclodextrin Symposium, Torino, Italy.

Zalfen, A., Nizet, D., Jérôme, C., Delattre, L., Frankenne, F., & Evrard, B. (2006). Multi-biomaterial for controlled release of active substances [Poster presentation]. European conference on Biomaterials, Nantes, France.

Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (November 2005). Effect of cyclodextrins on the membrane permeability of liposomes [Poster presentation]. 2nd EUFEPS conference on optimising drug delivery and formulation, Versailles, France.

Barillaro, V., Bertholet, P., Evrard, B., Delattre, L., Dive, G., & Piel, G. (September 2005). Inclusion of miconazole into cyclodextrins by means of supercritical carbon dioxide: effect of acidic ternary compound and molecular modelling study [Poster presentation]. 15th International Symposium on Microencapsulation, Parma, Italy.

Piel, G., Piette, M., Castagne, D., Barillaro, V., Evrard, B., & Delattre, L. (September 2005). Encapsulation of betamethasone-cyclodextrin inclusion complexes in liposmes: effect of cyclodextrins on the encapsulation efficinecy and the kinetic release of betamethasone [Poster presentation]. 15th International Symposium on Microencapsulation, Parma, Italy.

Bertholet, P., Jaspart, S., Bodson, C., Piette, M., Piel, G., Delattre, L., & Evrard, B. (June 2005). The effect of cyclodextrins on the aqueous solubility of a new MMP inhihbitor: phase solubility, 1H-NMR spectroscopy and molecular modelling studies, preparation and stability study of nebulizable solutions [Poster presentation]. 1st Pharmaceutical Sciences Fair and Exhibition (PharmSciFair), Nice, France.

Piette, M., Evrard, B., Frankenne, F., Chiap, P., Bertholet, P., Castagne, D., Foidart, J.-M., Delattre, L., & Piel, G. (June 2005). Pharmacokinetic study of a new syntheyic MMP inhibitor (Ro 28-2653) after IV and oral administration of solutions containing hydroxypropyl-b-cyclodextrin [Poster presentation]. 1st Pharmaceutical Sciences Fair and Exhibition (PharmSciFair), Nice, France.

Chiap, P., Piette, M., Evrard, B., Frankenne, F., Christiaens, B., Piel, G., Cataldo, D., Foidart, J.-M., Delattre, L., Crommen, J., & Hubert, P. (05 March 2005). Automated method for the determination of a new matrix metalloproteinase inhibitor in ovine plasma and serum by coupling of restricted access material for on-line sample clean-up to liquid chromatography. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 817 (1), 109-117. doi:10.1016/j.jchromb.2004.08.042

Piel, G., Piette, M., Castagne, D., Barillaro, V., Evrard, B., & Delattre, L. (March 2005). Influence des cyclodextrines sur la vitesse de libération de la bétamethasone encapsulée sous forme de complexe dans des liposomes [Paper presentation]. 8èmes Journées du Club français des Cyclodextrines, Nancy, France.

Piette, M., Evrard, B., Frankenne, F., Chiap, P., Bertholet, P., Castagne, D., Foidart, J.-M., Delattre, L., & Piel, G. (March 2005). Etude pharmacocinétique d'un nouvel inhibiteur des MMPs (I-col 51) après administration orale et intraveineuse de soultions à base d'hydroxypropyl-b-cyclodextrine [Paper presentation]. 8èmes Journées du Club français des Cyclodextrines, Nancy, France.

Barillaro, V., Evrard, B., Delattre, L., & Piel, G. (2005). Oral bioavailability in pigs of a miconazole/hydroxypropyl-gamma-cyclodextrin/L-tartaric acid inclusion complex produced by supercritical carbon dioxide processing. AAPS Journal, 7 (1), 149-E155. doi:10.1208/aapsj070116

Bertholet, P., Guéders, M., Dive, G., Albert, A., Barillaro, V., Perly, B., Cataldo, D., Piel, G., Delattre, L., & Evrard, B. (2005). The Effect of Cyclodextrins on the Aqueous Solubility of a New Mmp Inhibitor: Phase Solubility, 1 H-Nmr Spectroscopy and Molecular Modeling Studies, Preparation and Stability Study of Nebulizable Solutions. Journal of Pharmacy and Pharmaceutical Sciences, 8 (2), 164-175.

Guéders, M., Bertholet, P., Barillaro, V., Piel, G., Henry de Hassonville, S., Delattre, L., Cataldo, D., & Evrard, B. (2005). Evaluation of the pulmonary inflammation and bronchial hyperresponsiveness in healthy mice induced by inhaled cyclodextrins. In Journal of inclusion Phenomena and Macrocyclic Chesmistry.

Jaspart, S., Bertholet, P., Delattre, L., & Evrard, B. (2005). Study of solid lipid micriparticles as sustained release delivery system for pulmonary administration [Paper presentation]. 15th International symposium on microencapsulation, Parma, Italy.

Jaspart, S., Bodson, C., Bertholet, P., Delattre, L., & Evrard, B. (2005). In vitro release of salbutamol acetonide from solid lipid nanoparticles. In Proceedings of 1st Pharmaceutical Sciences Fair and Exhibition.

Jaspart, S., Piel, G., Delattre, L., & Evrard, B. (January 2005). Solid Lipid Microparticles: Formulation, Preparation, Characterisation, Drug Release and Applications. Expert Opinion on Drug Delivery, 2 (1), 75-87. doi:10.1517/17425247.2.1.75

Kirschvink, N., Leemans, J., Delvaux, F., Cambier, C., Evrard, B., Jaspar, S., Delattre, L., Clercx, C., & Gustin, P. (2005). Evaluation of the bronchoprotective effects of inhaled salmeterol, fenoterol and oxitropium in healthy cats. Fundamental and Clinical Pharmacology, 19, 237.

Leemans, J., Kirschvink, N., Delvaux, F., Cambier, C., Jaspart, S., Evrard, B., Delattre, L., Dogné, J. M., & Gustin, P. (2005). In vitro pharmacological activity of salbutamol acetonide on the isolated guinea-pig trachea and porcine bronchus. Fundamental and Clinical Pharmacology, 19, 237.

Leemans, J., Kirschvink, N., Delvaux, F., Cambier, C., Jaspart, S., Evrard, B., Delattre, L., Dogné, J. M., & Gustin, P. (2005). Comparison of bronchodilators in feline airways: In vitro and in vivo investigations. In In proceedings: 15th Congress European College of Veterinary Internal Medicine – companion animals (pp. 222).

Leemans, J., Kirschvink, N., Delvaux, F., Jaspart, S., Evrard, B., Delattre, L., Dogné, J. M., Cambier, C., & Gustin, P. (2005). In vitro and in vivo effects of salbutamol acetonide on cat airways. In Proceedings: Société Belge de Physiologie et de Pharmacologie Fondamentales et Cliniques.

Barillaro, V., Bertholet, P., Henry de Hassonville, S., Ziemons, E., Evrard, B., Delattre, L., & Piel, G. (30 November 2004). Effect of acidic ternary compounds on the formation of miconazole/cyclodextrin inclusion complexes by means of supercritical carbon dioxide. Journal of Pharmacy & Pharmaceutical Sciences : A Publication of the Canadian Society for Pharmaceutical Sciences, 7 (3), 378-388.

Henry de Hassonville, S., Chiap, P., Liégeois, J.-F., Evrard, B., Delattre, L., Crommen, J., Piel, G., & Hubert, P. (21 September 2004). Development and validation of a high-performance liquid chromatographic method for the determination of cyproterone acetate in human skin. Journal of Pharmaceutical and Biomedical Analysis, 36 (1), 133-143. doi:10.1016/j.jpba.2004.05.023

Roland, I., de Leval, X., Evrard, B., Pirotte, B., Dogné, J.-M., & Delattre, L. (August 2004). Modulation of the arachidonic cascade with omega 3 fatty acids or analogues: Potential therapeutic benefits. Mini Reviews in Medicinal Chemistry, 4 (6), 659-668. doi:10.2174/1389557043403738

Guéders, M., Bertholet, P., Barillaro, V., Piel, G., Henry de Hassonville, S., Delattre, L., Cataldo, D., & Evrard, B. (May 2004). Evaluation of the pulmonary inflammation and the bronchial hyperresponsiveness in healthy mice induced by inhaled cyclodextrins [Paper presentation]. XII th International Cyclodextrin Symposium, Montpellier, France.

Henry de Hassonville, S., Christiaens, B., Piel, G., Barillaro, V., Bertholet, P., Chiap, P., Hubert, P., Crommen, J., Delattre, L., Pierard, G., & Evrard, B. (May 2004). Effect of methylated-b-cyclodextrin on the skin and influence on cyproterone acetate percutaneous absorption [Poster presentation]. XII th International Cyclodextrin Symposium, Montpellier, France.

Evrard, B., Bertholet, P., Guéders, M., Flament, M. P., Piel, G., Delattre, L., Gayot, A., Leterme, P., Foidart, J.-M., & Cataldo, D. (2004). Cyclodextrins as a potential carrier in drug nebulization. Journal of Controlled Release, 96 (3), 403-410. doi:10.1016/j.jconrel.2004.02.010

Evrard, B., Hubert, P., Delvenne, P., Boniver, J., & Delattre, L. (2004). Development of a hydrogel containing GM-CSF to improve the dendritic cells colonisation of HPV+ epithelium. In Proceedings of Eur conference on drug delivery and pharmaceutical technology.

Henry de Hassonville, S., Christiaens, B., Piel, G., Barillaro, V., Bertholet, P., Chiap, P., Hubert, P., Crommen, J., Delattre, L., Pierard, G., & Evrard, B. (2004). La Rameb, un promoteur d’absorption cutanée pour l’acétate de cypro-térone ? [Paper presentation]. 7e journées du club cyclodextrines, Lille, France.

Henry de Hassonville, S., Dive, G., Evrard, B., Barillaro, V., Bertholet, P., Delattre, L., & Piel, G. (2004). Application of molecular modeling to the study of cyproterone acetate stability in the presence of cyclodextrin derivatives. Journal of Drug Delivery Science and Technology, 14 (5, SEP-OCT), 357-362. doi:10.1016/s1773-2247(04)50064-3

Hubert, P., Evrard, B., Maillard, C., Franzen-Detrooz, E., Delattre, L., Foidart, J.-M., Noël, A., Boniver, J., & Delvenne, P. (2004). Delivery of granulocyte-macrophage colony-stimulating factor in bioadhesive hydrogel stimulates migration of dendritic cells in models human papillomavirus-associated (pre)neoplastic epithelial lesions. Antimicrobial Agents and Chemotherapy, 48 (11), 4342-4348. doi:10.1128/AAC.48.11.4342-4348.2004

Jaspart, S., Bodson, C., Bertholet, P., Chiap, P., Delattre, L., & Evrard, B. (2004). Solid lipid Nanoparticles for administration by inhalation : Optimisation of manufacturing parameters [Paper presentation]. European Conference on Drug Delivery and Pharmaceutical Technology, Sevilla, Spain.

Jaspart, S., Kirschvink, N., Chiap, P., Delattre, L., Crommen, J., Gustin, P., & Evrard, B. (2004). Solid lipid Nanoparticles for administration by inhalation : Optimisation of manufacturing parameters and preliminary tolerance study [Paper presentation]. 12eme Forum des Sciences Pharmaceutiques, Blankenberge, Belgium.

Piel, G., Boulmedarat, L., Bochot, A., Evrard, B., Delattre, L., & Fattal, E. (January 2004). Etude des interactions cyclodextrines-liposomes: modification de la cinétique de libération de l'inuline encapsulée dans des lioposomes bioadhésifs en présence de méthyl-b-cyclodextrine [Paper presentation]. 7èmes Journées du Club français des Cyclodextrines, Lille, France.

Piel, G., Moutard, S., Perly, B., Henry de Hassonville, S., Bertholet, P., Barillaro, V., Piette, M., Delattre, L., & Evrard, B. (2004). Comparison of two methods currently used to determine the interaction between cyclodextrins and drugs: phase solubility diagrams and NMR spectroscopy. Journal of Drug Delivery Science and Technology, 14 (1, JAN-FEB), 87-91. doi:10.1016/s1773-2247(04)50010-2

Piel, G., Moutard, S., Uhoda, E., Pilard, F., Pierard, G., Perly, B., Delattre, L., & Evrard, B. (2004). Skin compatibility of cyclodextrins and their derivatives: a comparative assessment using a corneoxenometry bioassay. European Journal of Pharmaceutics and Biopharmaceutics, 57 (3), 479-82. doi:10.1016/j.ejpb.2003.12.004

Roland, I., Gillard, P., Delattre, L., Evrard, B., & de LA BRASSINNE, M. (2004). Characterisation of a novel topical nanoemulsion vehicle with spreading properties. In Proceedings of Eur conference on drug delivery and pharmaceutical technology.

Sanna, V., Kirschvink, N., Gustin, P., Gavini, E., Roland, I., Delattre, L., & Evrard, B. (2004). Preparation and in vivo toxicity study of solid lipid microparticles as carrier for pulmonary administration. AAPS PharmSci, 5 (2), 27. doi:10.1208/pt050227

Piel, G., Boulmedarat, L., Bochot, A., Evrard, B., Delattre, L., & Fattal, E. (12 November 2003). Influence de la methyl-b-cyclodextrine sur la cinetique de libération de l'inuline encapsulée dans des liposomes bioadhésifs [Poster presentation]. 18ème Journée Scientifique du GTRV, Lille, France.

Piel, G., Moutard, S., Uhoda, E., Pilard, F., Pierard, G., Perly, B., Delattre, L., & Evrard, B. (October 2003). The skin compatibility of new cyclodextrin derivatives: the phospholipidyl-cyclodextrins [Poster presentation]. Skin and Formulation, 1st Symposium, Paris, France.

Roland, I., Piel, G., Delattre, L., & Evrard, B. (16 September 2003). Systematic characterization of oil-in-water emulsions for formulation design. International Journal of Pharmaceutics, 263 (1-2), 85-94. doi:10.1016/S0378-5173(03)00364-8

Cataldo, D., Guéders, M., Rocks, N., Sounni, N. E., Evrard, B., Bartsch, P., Louis, R., Noël, A., & Foidart, J.-M. (September 2003). Pathogenic role of matrix metalloproteases and their inhibitors in asthma and chronic obstructive pulmonary disease and therapeutic relevance of matrix metalloproteases inhibitors. Cellular and Molecular Biology, 49 (6), 875-884.

Delattre, L., Henry de Hassonville, S., & Evrard, B. (04 June 2003). Hydrosoluble mixtures of cyproterone and/or an ester of it, processes to obtain them and uses thereof.

Bertholet, P., Cataldo, D., Guéders, M., Barillaro, V., Piel, G., Henry de Hassonville, S., Delattre, L., & Evrard, B. (May 2003). Effect of inhaled cyclodextrins on the pulmonary inflammation and bronchial hyperresponsiveness in mice [Paper presentation]. XIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Bertolla, C., Piette, M., Evrard, B., Delattre, L., Piel, G., Frédérick, R., & Masereel, B. (May 2003). Synthèse de b-cyclodextrines modifiées [Poster presentation]. 17th Journées Franco-belges de Pharmacochimie, Bruxelles, Belgium.

Henry de Hassonville, S., Dive, G., Prosperi, C., Perly, B., Piel, G., Barillaro, V., Bertholet, P., Delattre, L., Llabres, G., & Evrard, B. (May 2003). Influence of cyclodextrins on the solubility and the stability of cyproterone acetate [Paper presentation]. XIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Piel, G., Moutard, S., Uhoda, E., Pilard, F., Pierard, G., Perly, B., Delattre, L., & Evrard, B. (May 2003). An ex-vivo study of the skin compatibility of new cyclodextrin derivatives: the phospholipidyl-cyclodextrins [Paper presentation]. XIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Roland, I., Piel, G., Delattre, L., & Evrard, B. (May 2003). Systematic characterization of oil-in-water emulsion for formulation design [Paper presentation]. XIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Barillaro, V., Van Hees, T., Bertini, S., Piel, G., Bertholet, P., Henry de Hassonville, S., Evrard, B., & Delattre, L. (January 2003). Etude de l'inclusion du miconazole dans les cyclodextrines par le CO2 supercritique: caracterisation des complexes par HPLC, CP-MAS-NMR et FT-IR [Paper presentation]. 6èmes Journées du Club français des Cyclodextrines, Montpellier, France.

Bertholet, P., Guéders, M., Barillaro, V., Piel, G., Henry de Hassonville, S., Delattre, L., Cataldo, D., & Evrard, B. (January 2003). Etude de l'hyperactivité bronchique induite par l'administration pulmonaire de cyclodextrines chez la souris [Paper presentation]. 6èmes Journées du Club français des Cyclodextrines, Montpellier, France.

Henry de Hassonville, S., Christiaens, B., Piel, G., Barillaro, V., Bertholet, P., Chiap, P., Hubert, P., Crommen, J., Delattre, L., Pierard, G., & Evrard, B. (2003). Cyclodextrins as topical permeation enhancers : in vitro and in vivo testing [Poster presentation]. Symposium skin and formulation APGI, Paris, France.

Piel, G., Moutard, S., Uhoda, E., Pilard, F., Pierard, G., Perly, B., Delattre, L., & Evrard, B. (January 2003). Etude comparative de la tolérance cutanée de nouveaux dérivés amphiphiles de cyclodextrines: les phospholipidyl-cyclodextines [Paper presentation]. 6èmes Journées du Club français des Cyclodextrines, Montpellier, France.

Roland, I, Evrard, B., Erpicum, T, & Delattre, L. (2003). Formulation of submicronic emulsions by using a high-pressure homogeniser. Journal de Pharmacie de Belgique, 57, 68-70.

Roland, I., Gillard, P., Delattre, L., Evrard, B., & de LA BRASSINNE, M. (2003). Formulation and evaluation of a novel topical nanoemulsion vehicle with spreading properties [Poster presentation]. Symposium Skin and formulation, Paris, France.

Sanna, V., Kirschvink, N., Gustin, P., Gavini, E., Roland, I., Delattre, L., & Evrard, B. (2003). Solid lipid Nanoparticles for drug Pumonary Administration. In Proceedings of 30th International Symposium on Controlled Release of Bioactive Materials.

Evrard, B., Chiap, P., De Tullio, P., Ghalmi, F., Piel, G., Van Hees, T., Crommen, J., Losson, B., & Delattre, L. (13 December 2002). Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-beta-cyclodextrin. Journal of Controlled Release, 85 (1-3), 45-50. doi:10.1016/S0168-3659(02)00270-5

Van Hees, T., Barillaro, V., Piel, G., Bertholet, P., De Hassonville, S., Evrard, B., & Delattre, L. (December 2002). Application of Supercritical carbon dioxide for the preparation of drug-cyclodextrin inclusion compounds. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 44 (1-4), 271-274. doi:10.1023/A:1023084617964

Van Hees, T., Piel, G., Henry de Hassonville, S., Evrard, B., & Delattre, L. (May 2002). Determination of the free/included piroxicam ratio in cyclodextrin complexes: comparison between UV spectrophotometry and differential scanning calorimetry. European Journal of Pharmaceutical Sciences, 15 (4), 347-353. doi:10.1016/S0928-0987(02)00018-0

Piel, G., Moutard, S., Van Hees, T., Henry de Hassonville, S., Delattre, L., & Evrard, B. (April 2002). Determination of the interaction between cyclodextins and drugs: comparison of two methods (phase solubility diagrams and NMR) [Poster presentation]. 4th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Firenze, Italy.

Barillaro, V., Van Hees, T., Piel, G., Henry de Hassonville, S., Bertholet, P., Evrard, B., & Delattre, L. (February 2002). Influence de l'ajout d'un composé ternaire dans la formation d'un complexe d'inclusion de miconazole dans les cyclodextrines par CO2 supercritique [Paper presentation]. 5ème Journée du Club français des Cyclodextrines, Amiens, France.

Henry de Hassonville, S., Perly, B., Piel, G., Van Hees, T., Barillaro, V., Betholet, P., Evrard, B., & Delattre, L. (February 2002). Augmentation de la solubilité de l'acétate de cyprotérone par formation de complexes d'inclusion dans les cyclodextrines [Paper presentation]. 5èmes Journées du Club français des Cyclodextrines, Amiens, France.

Henry de Hassonville, S., Perly, B., Piel, G., Van Hees, T., Delattre, L., & Evrard, B. (2002). Inclusion Complexes of Cyproterone Acetate with Cyclodextrins in Aqueous Solution. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 44, 289-292. doi:10.1023/A:1023099611604

Otte, X, Evrard, B., Delattre, L., & Thunus, L. (2002). Development and validation of a new Fourier transform infrared spectrometric method for the quantification of urea in creams and ointments. Analytica Chimica Acta, 451, 323-328. doi:10.1016/S0003-2670(01)01416-7

Piel, G., Hayette, M.-P., Pavoni, E., Evrard, B., Van Hees, T., Henry de Hassonville, S., De Mol, P., & Delattre, L. (July 2001). In Vitro Comparison of the Antimycotic Activity of a Miconazole-Hp-Beta-Cyclodextrin Solution with a Miconazole Surfactant Solution. Journal of Antimicrobial Chemotherapy, 48 (1), 83-7. doi:10.1093/jac/48.1.83

Piel, G., Dive, G., Evrard, B., Van Hees, T., Henry de Hassonville, S., & Delattre, L. (June 2001). Molecular Modeling Study of Beta- and Gamma-Cyclodextrin Complexes with Miconazole. European Journal of Pharmaceutical Sciences, 13 (3), 271-9. doi:10.1016/S0928-0987(01)00113-0

Alvarez, C., Van Hees, T., Piel, G., Liégeois, J.-F., Delattre, L., & Evrard, B. (2001). Preparation of mebendazole HP-beta-cyclodextrin complexes using water-soluble polymers and organic acids. STP Pharma Sciences, 11 (6), 439-442.

Alvarez, C, Van Hees, T., Piel, G., Liégeois, J.-F., Evrard, B., Torrado, J.J, & Delattre, L. (2001). Préparation de complexes mebendazole-HPβCD à l'aide de polymères solubles dans l'eau et d'acides organiques. Annales Pharmaceutiques Françaises, 59, 380.

Piel, G., Llabres, G., Evrard, B., Van Hees, T., Henry de Hassonville, S., & Delattre, L. (2001). A nuclear magnetic resonance study of the miconazole-b-cyclodextrin inclusion complex in an acidic medium: determination of the structure and stability constants. STP Pharma Sciences, 11 (3), 235-238.

Roland, I., Evrard, B., Erpicum, T., & Delattre, L. (2001). Formulation of subcronic emulsions by using a high-pressure homogeniser [Paper presentation]. 10th Forum of Pharmaceutical Sciences, Montreal, Canada.

Roland, I., Evrard, B., Erpicum, T., & Delattre, L. (2001). Formulation and characterisation of submicronic emulsions [Paper presentation]. International Symposium on Material Characterisation an Technology, Bruxelles, Belgium.

Alvarez, C., Van Hees, T., Piel, G., Liégeois, J.-F., Evrard, B., Torrado, J., & Delattre, L. (December 2000). Préparation de complexes mébendazole-HPbCD à l'aide de polymères solubles dans l'eau et d'acides organiques [Paper presentation]. 4ème Journée du Club français des Cyclodextrines, Grenoble, France.

Piel, G., Pavoni, E., Evrard, B., Van Hees, T., Henry de Hassonville, S., & Delattre, L. (December 2000). Etude comparative de l'effet de différents acides et de différentes cyclodextrines sur la solubilité du miconazole, du kétoconazole et de l'itraconazole [Paper presentation]. 4ème Journée du Club français des Cyclodextrines, Grenoble, France.

Van Hees, T., Piel, G., Evrard, B., Henry de Hassonville, S., & Delattre, L. (December 2000). Solubility of p-hydroxybenzoic esters in supercritical carbon dioxide [Poster presentation]. 7th Meeting on Supercritical Fluids, Antibes, France.

Piel, G., Evrard, B., Van Hees, T., Hayette, M.-P., De Mol, P., & Delattre, L. (May 2000). Development of a new parenteral solution of miconazole by the use of cyclodextrins derivatives [Poster presentation]. Xth International Cyclodextrin Symposium, Michigan, United States.

Piel, G., Evrard, B., Van Hees, T., Pierard, G., de LA BRASSINNE, M., & Delattre, L. (May 2000). Development of a cutaneous hydrogel containing miconazole by the useof hydroxypropyl-b-cyclodextrin and lactic acid [Poster presentation]. Xth International Cyclodextrin Symposium, Michigan, United States.

Alvarez, C., Van Hees, T., Piel, G., Liégeois, J.-F., Evrard, B., Torrado, J., & Delattre, L. (April 2000). Preparation of mebendazole HP-b-cyclodextrin complexes using water soluble polymers and organic acids [Paper presentation]. IXth Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Piel, G., Evrard, B., Van Hees, T., Pierard, G., de LA BRASSINNE, M., & Delattre, L. (April 2000). Development of a cutaneous hydrogel containing miconazole hydroxypropyl-b-cyclodextrin and lactic acid: study of its tolerability and efficacy [Paper presentation]. IXth Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Chiap, P., Evrard, B., Bimazubute, M. A., De Tullio, P., Hubert, P., Delattre, L., & Crommen, J. (10 February 2000). Determination of Albendazole and Its Main Metabolites in Ovine Plasma by Liquid Chromatography with Dialysis as an Integrated Sample Preparation Technique. Journal of Chromatography. A, 870 (1-2), 121-34. doi:10.1016/S0021-9673(99)00938-3

Van Hees, T., Evrard, B., Piel, G., & Delattre, L. (2000). Inclusion of Piroxicam into Beta-Cyclodextrin by Means of Supercritical Carbon Dioxide: Thermal, Spectroscopic and Physicochemical Studies. Journal de Pharmacie de Belgique, 55 (1, Jan-Feb), 30-1.

Van Hees, T., Piel, G., Evrard, B., Otte, X., Thunus, L., & Delattre, L. (December 1999). Application of Supercritical Carbon Dioxide for the Preparation of a Piroxicam-Beta-Cyclodextrin Inclusion Compound. Pharmaceutical Research, 16 (12), 1864-70. doi:10.1023/A:1018955410414

Evrard, B., Amighi, K., Beten, D., Delattre, L., & Moes, A. J. (November 1999). Influence of Melting and Rheological Properties of Fatty Binders on the Melt Granulation Process in a High-Shear Mixer. Drug Development and Industrial Pharmacy, 25 (11), 1177-84. doi:10.1081/DDC-100102285

Evrard, B., & Delattre, L. (06 October 1999). SUSTAINED RELEASE PHARMACEUTICAL TABLETS WITH TRAMADOL BASE AND THEIR PREPARATION.

Piel, G., Hayette, M.-P., Evrard, B., Van Hees, T., De Mol, P., & Delattre, L. (May 1999). A comparative study of the antimycotic activity of a miconazole-HP-b-CD solution to a surfactant solution [Paper presentation]. VIIIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Van Hees, T., Evrard, B., Piel, G., & Delattre, L. (May 1999). Inclusion of piroxicam into b-cyclodextrin by means of supercritical carbon dioxide: thermal, spectroscopic and physicochemical studies [Paper presentation]. VIIIth Forum of Pharmaceutical Sciences.

Piel, G., Evrard, B., Van Hees, T., & Delattre, L. (25 March 1999). Comparison of the Iv Pharmacokinetics in Sheep of Miconazole-Cyclodextrin Solutions and a Micellar Solution. International Journal of Pharmaceutics, 180 (1), 41-5. doi:10.1016/S0378-5173(98)00403-7

Chiap, P., Evrard, B., Bimazubute, M., De Tullio, P., Hubert, P., Delattre, L., & Crommen, J. (1999). On-line combinaison of dialysis with liquid chromatography for the automated determination of albendazole and its main metabolites in ovine plasma [Paper presentation]. VIIIème Forum des Sciences Pharmaceutiques, Spa, Belgium.

Chiap, P., Hubert, P., Bimazubute, M., Evrard, B., Delattre, L., & Crommen, J. (1999). LC determination of albendazole and its main metabolites in ovine plasma using dialysis as integrated sample preparation technique [Poster presentation]. XXIIIrd International Symposium on High Performance Liquid Phase Separations and Related Techniques, Grenade, Spain.

Evrard, B., De Tullio, P., Chiap, P., Van Hees, T., Piel, G., Crommen, J., Losson, B., & Delattre, L. (1999). The effect of hydroxypropyl-b-cyclodextrins on the pharamacokinetics of albendazole in sheep. In Proceedings of 26th International Symposium on Controlled Release of Bioactive Materials.

Nikkels, A., Frere, P., Rakic, L., Fassotte, M.-F., Evrard, B., De Mol, P., & Pierard, G. (1999). Simultaneous Reactivation of Herpes Simplex Virus and Varicella-Zoster Virus in a Patient with Idiopathic Thrombocytopenic Purpura. Dermatology, 199 (4), 361-364. doi:10.1159/000018292

Piel, G., Evrard, B., Van Hees, T., Llabres, G., & Delattre, L. (1999). Development of a parenteral and of an oral formulation of albendazole with cyclodextrins. STP Pharma Sciences, 3, 257-260.

Piel, G., Hayette, M.-P., Evrard, B., Van Hees, T., De Mol, P., & Delattre, L. (1999). A Comparative Study of the Antimycotic Activity of a Miconazole Hp-Beta Cyclodextrin Solution and a Surfactant Solution. Journal de Pharmacie de Belgique, 54 (3, May-Jun), 87-8.

Chiap, P., Planck, I., Evrard, B., Hubert, P., Delattre, L., & Crommen, J. (1998). Automated determination of acyclovir in human plasma using solid phase extraction and liquid chromatography. Journal de Pharmacie de Belgique, 53, 172.

Evrard, B., Chiap, P., Piel, G., Van Hees, T., Ghalmi, F., Losson, B., & Delattre, L. (1998). Influence of cyclodextrins on the solubility and the pharmacokinetics of albendazole [Poster presentation]. IXth International Cyclodextrin Symposium, Santiago de Compostela, Spain.

Evrard, B., Piel, G., Van Hees, T., Ghalmi, F., Losson, B., & Delattre, L. (1998). Development and pharmacokinetic evaluation of an oral liquid formulation of albendazole with cyclodextrins [Poster presentation]. 2th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Paris, France.

Otte, X., Duvivier, F., Evrard, B., & Thunus, L. (1998). New developments in quantitative analysis and trace analysis in pharmaceutical matrices by FTIR. In Proceedings de la journée de rencontre des jeunes chimistes mars 1998 (pp. 107).

Piel, G., Evrard, B., Fillet, M., Llabres, G., & Delattre, L. (1998). Development of a non-surfactant parenteral formulation of miconazole by the use of cyclodextrins. International Journal of Pharmaceutics, 169, 15-22. doi:10.1016/S0378-5173(98)00103-3

Piel, G., Evrard, B., Van Hees, T., Fernandez del Pozo, C., & Delattre, L. (1998). Development of a sustained release dosage form diclofenac-cyclodextrin inclusion complex [Poster presentation]. IX th International Cyclodextrin Symposium, Santiago de Compostela, Spain.

Piel, G., Llabres, G., Fillet, M., Evrard, B., Van Hees, T., & Delattre, L. (1998). A proton nuclear resonance study of the inclusion complex of miconazole with b-cyclodextrin in an acidic medium [Poster presentation]. 2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Paris, France.

Piel, G., Van Hees, T., Evrard, B., & Delattre, L. (1998). A comparative pharmacokinetic study of intravenous solutions containig miconazole with or without cyclodextrins [Poster presentation]. IXth International Cyclodextrin Symposium, Santiago de Compostela, Spain.

Van Hees, T., Evrard, B., Piel, G., & Delattre, L. (1998). A comparative study of the dissolution properties of piroxicam-b-cyclodextrin inclusion complexes prepared by different methods [Poster presentation]. IXth International Cyclodextrin Symposium, Santiago de Compostela, Spain.

Van Hees, T., Piel, G., Evrard, B., & Delattre, L. (1998). Preparation of a drug-b-cyclodextrin inclusion compound using supercritical carbon dioxide [Poster presentation]. 2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Paris, France.

Evrard, B., Piel, G., Ceccato, A., & Delattre, L. (July 1997). Effects of cyclodextrins on the solubility characteristics of albendazole [Poster presentation]. Pharmaceutical appplication of Cyclodextrins Conference, Lawrence, Kansas, United States.

Piel, G., Evrard, B., & Delattre, L. (July 1997). Study of the combined effects of cyclodextrins and buffer type on the solubility of miconazole [Poster presentation]. Pharmaceutical applications of cyclodextrins conference, Lawrence, Kansas, United States.

Piel, G., Fillet, M., Evrard, B., Crommen, J., & Delattre, L. (July 1997). Comparison of the binding constant values of complexes of different antimycotic imidazole derivatives with cyclodextrin obtained by capillary electrophoresis and phase solubility diagram [Poster presentation]. Pharmaceutical applications of cyclodextrins conference, Lawrence, Kansas, United States.

Evrard, B., Ceccato, A., Gaspard, O., Delattre, L., & Delporte, J.-P. (01 May 1997). Stability of Ondansetron Hydrochloride and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Injection and in 5% Dextrose Injection. American Journal of Health-system Pharmacy, 54 (9), 1065-8. doi:10.1093/ajhp/54.9.1065

Piel, G., Evrard, B., & Delattre, L. (April 1997). Multicomponent complexes of miconazole with different acids and cyclodextrins [Paper presentation]. VIIth Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Duvivier, F., Grandfils, C., Léonard, F., Evrard, B., & Delattre, L. (1997). The size of nanoparticles after their incorporation in gastroresistant spheroids. Journal de Pharmacie de Belgique, 52 (3), 123.

Duvivier, F, Grandfils, C., Léonard, F, Evrard, B., & Delattre, L. (1997). Etude de la taille des nanoparticules après incorporation dans des sphéroïdes gastrorésistants. Journal de Pharmacie de Belgique, 52 (3), 123.

Duvivier, F., Grandfils, C., Léonard, F., Evrard, B., & Delattre, L. (1997). Development of a nanoparticular oral delivery system : study of the size of the nanoparticles after incorporation into gastroresistant pellets [Paper presentation]. 7th Forum of Pharmaceutical Sciences.

Duvivier, F., Lübbering, B., Léonard, F., Evrard, B., Goffinet, G., & Delattre, L. (1997). Influence of the amount of enteric polymer on the disintegration rate of pellets designed for protein delivery : in vitro and in vivo tests. In Proceedings of Symposium on Particulate Systems, From Formulation to Prduction.

Piel, G., Evrard, B., & Delattre, L. (1997). Complexes à multicomposants de miconazole avec différents acides et cyclodextrines. Journal de Pharmacie de Belgique, 52 (3), 124.

Evrard, B., Ceccato, A., Colson, A., Léonard, F., Gaspard, O., Delporte, J.-P., & Delattre, L. (1996). Stability of ondansetron hydrochloride and dexamethazone sodium phosphate admixtures in injectable solutions [Paper presentation]. Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Evrard, B., & Delattre, L. (1996). In vitro evaluation of lipid matrices for the development of a sustained-release sulfamethazine bolus for lambs. Drug Development and Industrial Pharmacy, 22 (2), 111-118. doi:10.3109/03639049609041980

Evrard, B., & Delattre, L. (1996). Formes pharmaceutiques à libération prolongée en médecine vétérinaire : systèmes à rétention dans le réticulo-rumen = Sustained-released veterinary dosage forms : retention devices in the reticulorumen. STP Pharma Pratiques, 6 (6), 479-486.

Evrard, B., Delahaut, P., Hubert, P., Crommen, J., & Delattre, L. (1995). Biopharmaceutical aspects of the development of a sulfamethazine oral sustained release bolus for lambs. Journal of Controlled Release, 35, 107-115. doi:10.1016/0168-3659(95)00025-4

Evrard, B., & Delattre, L. (1995). Evaluation of the correlation between "in vitro" and "in vivo" release of sulfamethazine from a long-acting ovine bolus. In Proceedingsof 1st World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (pp. 927-928).

Evrard, B., Hubert, P., Chiap, P., Crommen, J., & Delattre, L. (1995). A fully automated HPLC method for pharmacokinetic studies on a long-acting sulfamethazine veterinary bolus [Paper presentation]. 5th International Symposium on Drug Analysis, Leuven, Belgium.

Evrard, B., Hubert, P., Chiap, P., Crommen, J., & Delattre, L. (1995). A fully automated HPLC method for pharmacokinetic studies on a long-acting sulfamethazine veterinary bolus. Journal de Pharmacie de Belgique, 50, 328.

Evrard, B. (1994). Développement d'une forme galénique orale à libération prolongée en Médecine Vétérinaire : Mise au point d'un bolus à rétention dans le réticulo-rumen [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/37516

Evrard, B., Delahaut, P., & Delattre, L. (1994). Pharmacokinetic evaluation of a long-acting sulfamethazine bolus for lambs. In Proceedings of 21th International Symposium on controlled release of Bioactive Materials.

Hubert, P., Chiap, P., Evrard, B., Delattre, L., & Crommen, J. (08 December 1993). Fully Automated Determination of Sulfamethazine in Ovine Plasma Using Solid-Phase Extraction on Disposable Cartridges and Liquid Chromatography. Journal of Chromatography. A, 622 (1), 53-60. doi:10.1016/0378-4347(93)80249-4

Evrard, B., Chapelle, J.-P., & Gielen, J. (May 1993). Evaluations of an immunonephelometric assay for serum lipoprotein (a) [Poster presentation]. 5th International Symposium on New Biochemical merkers in Cardiovascular disease and flow cytometry in laboratory medicine, Brugge, Belgium.

Evrard, B., Peerboom, C., & Delattre, L. (1993). Evaluation of a new laboratory high-shear mixer [Paper presentation]. Forum des Sciences Pharmaceutiques, Blankenberge, Belgium.

Delneuville, I., Evrard, B., Kapusta, D., Dechesne, J.-P., & Delattre, L. (1992). Développement galénique d'une forme matricielle à libération prolongée renfermant un actif hydrosoluble. In Proceedings of 6th International Conference of Pharmaceutical Technology.

Evrard, B., Dechesne, J.-P., Fagetton, X., & Delattre, L. (1992). Development of a sustained release bolus for sheep : "in vitro" and "in vivo" results. In Proceedings of 19th International Symposium on controlled release of Bioactive Materials (pp. 435-436).

Evrard, B., Dechesne, J.-P., Fagetton, X., Zygraich, N., & Delattre, L. (1992). Development of a long-acting sulfamethazine bolus for sheep. In Proceedings of 6th International Conference of Pharmaceutical Technology (pp. 114-122).

Evrard, B., & Delattre, L. (1992). Melt-Granulation with a new laboratory high-shear mixer. In Proceedings of 6th International Conference of Pharmaceutical Technology.

Evrard, B., & Delattre, L. (1992). Development of a long acting sulfamethazine bolus for sheep [Paper presentation]. Second European Symposium on Controlled Drug Delivery, Noordwijk aan Zee, Netherlands.

Hubert, P., Evrard, B., Delattre, L., & Crommen, J. (1992). Automated determination of sulfadimidine in ovine plasma by solid phase extraction and HPLC. Journal de Pharmacie de Belgique, 47, 197.

Evrard, B., Gougnard, T., & Delattre, L. (March 1991). Cystéamine therapy for children with nephropathic cystinosis : stability of cysteamine in eyedrops and drinkable solutions [Paper presentation]. Forum des Sciences Pharmaceutiques, Houffalize, Belgium.

Evrard, B. (1991). Développement d'une forme galénique orale à libération prolongée en Médecine Vétérinaire : Mise au point d'un bolus à rétention dans le réticulo-rumen [Specialised master, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/37529

Evrard, B., Dechesne, J.-P., Fagetton, X., Zygraich, N., & Delattre, L. (March 1990). Development of a sustained release bolus for lambs [Paper presentation]. Forum des Sciences Pharmaceutiques, De Haan, Belgium.

Bontemps, J., Pirson, P., Falmagne, J.-B., Jérôme, R., Theyssie, P., Delattre, L., & Evrard, B. (01 February 1989). MICROPARTICLES COMPRISING A BIODEGRADABLE POLYMER CONTROLLING THE RELEASE OF AN ANTIMALARIAL DRUG, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR THEIR PREPARATION.

Evrard, B., Delattre, L., & Dechesne, J.-P. (1987). Stabilité des collyres à base de chlorhydrate de cystéine. Pharmakon, 69, 7-10.

Evrard, B., Dechesne, J.-P., & Delattre, L. (December 1986). Influence of propyleneglycol, dimethylisosorbide and isopropylmyristate on in vitro release of an antihistaminic drug from a transdermal therapeutic system [Poster presentation]. Neu-Ulm Conferance on transdermal Drug delivery, Neu Ulm, Germany.

Delattre, L., & Evrard, B. (1985). Mise au point d'une formulation d'un gel topique à base de Dermovate lotion. Journal de Pharmacie de Belgique, 40 (5), 343-344.